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ABSTRACT 
Lung macrophages (LMϕs) play a key role in pulmonary innate immunity. They 
polarize into different phenotypes adapting to the needs of the immediate pulmonary 
environment, and adjust their functional responses via autocrine signalling. Previous studies 
in our laboratory suggest that murine LMϕs are endowed with an autocrine gamma-
aminobutyric acid (GABA) signaling system. My honors thesis study found that 
antagonizing the autocrine GABA signaling in alveolar macrophages (AMϕs) increased the 
secretion of the M1 cytokine tumor necrosis factor-alpha (TNF-α), suggesting a role for 
GABA signaling in immune response. This thesis project explored whether GABA signaling 
plays a role in LMϕ polarization. As previously reported, results from this study confirmed 
that bacterial toxin lipopolysaccharide (LPS) and the Th1 cytokine interferon gamma (IFNγ) 
shifted LMϕs to the pro-inflammatory M1 phenotype, marked by increased expression of 
inducible nitric oxide synthase (iNOS). On the other hand, the Th2 cytokines interleukin 
(IL)-4 and IL-13 shifted LMϕs toward the M2 phenotype marked by increased arginase-1. 
Importantly, in both RAW 264.7 cell line and primary LMϕs, LPS and IFNγ treatment 
increased iNOS expression while decreasing glutamic acid decarboxylase (GAD) and A-
type GABA receptor α2-subunit (α2-GABAAR). Conversely, treatment with IL4/13 induced 
an upregulation of arginase-1, GAD, and α2-GABAAR. Moreover, treatment of primary 
LMϕs with IL4/13 and GABAAR antagonist picrotoxin decreased arginase-1 and GAD 
expression, and increased iNOS levels. These results suggest that the autocrine GABA 
signaling system in LMϕs dynamically changes along with their phenotypic polarization. 
This signaling system functions to limit the M1 response but facilitate M2 responses, and 
thus a change in the GABA signaling may alter the inflammatory responses of these cells. 
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1.0 INTRODUCTION 
 
1.1 Preface 
Macrophages are a primary mediator of the innate immune system, and exist in almost 
every tissue of the body. While all parts of the mammalian body require protection from 
pathogens, perhaps the most important loci for host defence are organs that are exposed to 
the external environment including the gastrointestinal tract and the lungs. In these tissues 
macrophages are the predominant type of immune cell. In order to adapt to the needs of the 
immediate pulmonary environment, alveolar macrophages (AMϕs) polarize in response to 
infectious pathogens as well as cytokines secreted from nearby T cells. For example, 
bacterial toxin lipopolysaccharide (LPS) and T helper (Th) 1 cytokines such as interferon 
gamma (IFNγ) stimulate AMϕs to shift to the pro-inflammatory M1 phenotype, marked by 
the upregulation of inducible nitric oxide synthase (iNOS). M2 polarization is typically 
characterized by upregulation of arginase-1 and can be prompted by parasite infection and/or 
Th2 cytokines such as interleukin-4 (IL-4) and IL-13. More detailed descriptions of M1/M2 
polarization may be found in section 1.4. 
Studies in my lab suggest that AMϕs are endowed with an autocrine gamma-
aminobutyric acid (GABA) signalling system. More specifically, AMϕs express the GABA-
synthesizing enzyme glutamic acid decarboxylase (GAD) and A-type GABA receptors 
(GABAARs). However, whether the autocrine GABA signalling plays a role in AMϕ 
polarization remains to be investigated. My thesis focuses on the role of GABA signalling 
in the regulation of AMϕ polarization. 
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1.2 Macrophage lineage 
1.2.1 Macrophage hematopoiesis 
  Hematopoiesis is the process of generating blood cells from stem cell origins. The 
genesis of the blood cells is complex, with shifting sites of hematopoiesis occurring during 
development. There are two waves of macrophage hematopoiesis: primitive and definitive 
(McGrath et al., 2015). Primitive hematopoiesis occurs before birth in the ectoderm of the 
yolk sac and results in macrophages populating the tissues without the need of monocyte 
progenitors (Italiani and Boraschi, 2014). In the murine embryo, examination of embryonic 
macrophage and monocyte populations reveals that the first wave of macrophage 
hematopoiesis arises in the yolk sac (Gomez Perdiguero et al., 2015; Hoeffel et al., 2015). 
These macrophage progenitors are the source of early macrophages throughout the 
embryonic tissues including the brain, where macrophage progenitors develop into microglia 
(Ginhoux et al., 2010). These macrophages bypass the monocytic intermediate stage. 
The second wave of hematopoiesis, also in the yolk sac, gives rise to multipotent 
erythro-myeloid progenitors (EMPs) that colonize the fetal liver, initiating myelopoiesis 
(McGrath et al., 2015).  Macrophages generated from the second hematopoietic wave are 
distributed in most fetal tissues before the onset of fetal monocyte production by the fetal 
liver (Gomez Perdiguero et al., 2015; Frame et al., 2013). These primitive macrophages 
retain a high proliferative potential and participate in many fundamental processes during 
mid and late embryogenesis, including definitive macrophage hematopoiesis and in the 
clearance of dead cells during tissue maturation. Definitive hematopoiesis of myeloid 
progenitors takes place in the fetal liver during embryogenesis, and then in the bone marrow 
after birth. More precisely, EMPs in the fetal liver become the source circulating monocytes 
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during embryogenesis, and following birth and bone development, the definitive 
hematopoiesis process relocates to the bone marrow (Italiani and Boraschi, 2014). The 
hematopoietic systems in humans and mice are coordinated in a similar manner (Tavian & 
Péault, 2005). 
 
1.2.2 Monocytes 
  Monocytes are circulating phagocytic white blood cells that are derived from EMPs 
during definitive hematopoiesis and spread to various organs where they differentiate into 
macrophages (Shi & Pamer, 2011; Goncalves et al., 2011). Circulating monocytes were 
thought to replace tissue-resident macrophages as the host matures (van Furth & Cohn, 
1968). However new evidence suggests tissue-resident macrophages are largely derived 
during primitive hematopoiesis in the yolk sac, populate the tissue before birth, and are 
capable of self-renewal continuing into adulthood (Schulz et al., 2012; Sieweke & Allen, 
2013, Epelman et al., 2014). For example, tissue macrophages are able to maintain 
population size in the absence of monocyte precursors in homeostatic conditions, as well as 
during monocytopenia (Schulz et al., 2012, Yona et al., 2013, Jakubzick et al., 2013). In 
addition, following lung macrophage depletion, repopulation occurred in situ rather than by 
infiltration of blood monocytes (Hashimoto et al., 2013). Therefore, it is believed that 
monocytes are not generally necessary for maintenance of tissue-resident macrophage 
populations during homeostatic conditions. Instead, monocyte activity appears to mainly 
provide additional macrophages to the tissue necessary for resolution of acute inflammation 
(Jenkins & Hume, 2014).  
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Monocytes only remain in the bloodstream for 1-2 days, during which time they must 
be recruited to tissue by an inflammatory response or they will perish and be replaced 
(Italiani and Boraschi, 2014). There are two specific subtypes of monocytes defined by 
chemokine receptor expression in mice. The GR-1high CCR2high CX3CR1
low monocytes are 
pro-inflammatory and migrate to infected sites to assist with pathogenic clearance (Herold 
et al., 2011). The GR-1low CCR2low CX3CR1
high monocytes populate both healthy and 
infected areas, and are involved in resolution of inflammation and tissue repair (Auffray et 
al., 2007; Geissmann et al., 2010). During inflammatory responses GR-1high CCR2high 
CX3CR1
low monocytes are recruited by chemokines, including monocyte chemoattractant 
protein-1 and Growth-related oncogene-α, released from pro-inflammatory tissue resident 
macrophages (Barnes 2004; Herold et al., 2011). Upon arrival to the tissue, recruited 
monocytes differentiate into monocyte-derived inflammatory macrophages, and assist the 
elimination of pathogens by phagocytosis, and nitric oxide (NO) production (Serbina et al., 
2008). Monocyte-derived inflammatory macrophages also assist the inflammatory responses 
by secreting pro-inflammatory cytokines that induce T-cell polarization (Serbina et al., 2008; 
Evans et al., 2009) 
 
1.3 Macrophages 
1.3.1 Resident macrophages 
Macrophages represent 10-15% of the total cell number during homeostasis and are 
the first line of defence of the innate immune system. (Murray & Wynn, 2011; Italiani and 
Boraschi, 2014). Generally, resident macrophages proliferate regularly to maintain their 
population at steady state, without the need for repopulation by monocyte progenitor cells 
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(Sieweke & Allen, 2013). Many types of resident macrophages exist, each of which express 
different transcription profiles based on the needs of the environment. Therefore, each type 
of tissue resident macrophage is unique and is assigned a specific name according to tissue 
location such as microglia in the central nervous system, Kupffer cells in the liver, and 
alveolar macrophages in pulmonary alveoli (Gautier et al., 2012). Despite differences at the 
transcriptional level, the roles of macrophages in each tissue are in general similar. They are 
an integral component of tissue development, tissue surveillance and initiation of 
inflammatory response to pathogen, and maintenance of tissue homeostasis by clearing 
cellular debris and repairing tissue (Maus et al., 2002; Italiani and Boraschi, 2014).  
Macrophages express cytosolic and membrane bound pattern recognition receptors 
(PRRs), including Toll like-receptors (TLRs), which recognize pathogen-associated 
molecular patterns (PAMPs) (Akira et al., 2006). Within an hour of PAMP detection, 
macrophages initiate inflammation to attempt to sterilize the area of infection (Chen & 
Nunez, 2010). During the initial phase of inflammatory responses, it becomes necessary to 
increase the population of pro-inflammatory cytokine secreting cells in order to produce a 
complete inflammatory response. The local increase in inflammatory macrophages is 
generally accomplished by recruitment of neutrophils, a type of leukocyte. Neutrophils are 
an important component of the acute inflammatory response, both by bacterial killing and 
secretion of chemokines such as CCL2 which will ultimately aid in the recruitment of blood 
monocytes (Kolaczkowska & Kubes, 2013). Upon exposure to the pro-inflammatory 
environment, exudated monocytes become monocyte-derived inflammatory macrophages 
and further propagate the inflammatory response (Italiani and Boraschi, 2014). 
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1.3.2 Lung macrophages 
Macrophages are the most abundant immune cell in the lung and are strategically 
positioned to play a pivotal role in airway defence (Byrne et al., 2015). Lung macrophages 
(LMϕ) have dual origins: an F4/80High population derived from primitive yolk sac 
representing the majority of lung macrophages including AMϕs, along with a smaller 
population of F4/80Low of definitive hematopoetic origin which are continually replaced 
(Yona et al., 2013). There are two primary subtypes of lung macrophages: alveolar 
macrophages, and interstitial macrophages (IMϕs). The two macrophage subtypes may be 
distinguished based on their expression patterns of integrins cluster of differentiation (CD) 
11b and CD11c. AMϕs express high levels of CD11c and lack CD11b, whereas IMϕs and 
recruited monocytes possess the opposite expression pattern (Hussel & Bell, 2014).  
 
Alveolar macrophages 
AMϕs are the predominant immune effector cell in the alveolar space and the 
conducting airways. AMϕs exist in a unique environment which is directly exposed to the 
external environment, contains high partial pressure of oxygen, and high lipid 
concentrations. This environment setting differentiates AMϕs from other types of 
macrophages, and therefore AMϕs exhibit vastly different characteristics. For example, 
under homeostatic conditions AMϕs have an incredibly long life span with a half-life which 
exceeds 12 months, in stark contrast to peritoneal macrophages which exhibit a half-life of 
merely 15 days (Janssen et al., 2011). Another unique property of AMϕs is how the 
population changes over the course of inflammation and resolution phases. Tissue 
macrophages in general have been described as polarizing from M2 to M1 upon stimulation 
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with a pathogen, along with recruitment of monocytes to fight the infection and clear dead 
cells (Romo et al., 2011). Following pathogenic clearance, the M1 tissue macrophages were 
thought to perish due to their own NO production, and eventually the tissue would be 
repopulated by monocytes in the absence of pro-inflammatory signals (Mills 2012; Italiani 
and Boraschi, 2014). However, a study by Janssen et. al demonstrated that AMϕs follow a 
much different process, whereby the resident AMϕ population remained stable throughout 
the inflammatory response and recruited monocytes are wholly responsible for increase in 
macrophage numbers during the inflammatory response. Furthermore, during the resolution 
phase recruited monocytes/macrophages undergo in situ programmed cell death and are 
phagocytosed by neighboring tissue macrophages (Janssen et al., 2011).  
 
Interstitial macrophages in the lung 
Whereas AMϕs are found in the airways and are directly exposed to the external 
environment, IMϕs reside inside the lung tissue (Byrne et al., 2015). In the lung, as a whole, 
IMϕs are roughly two times less abundant than AMϕs. IMϕs have a low phagocytic potential 
relative to AMϕs but play a very important role regarding antigen presentation and express 
much higher levels of MHC class II molecules than AMϕs (Bedoret et al., 2009). Due to 
their antigen-presenting capability the primary focus of IMϕs is to interact with interstitial 
lymphocytes in order to initiate a specific immune response, which is distinct from AMϕs 
which are more effective as non-specific first line of defence (Franke-Ullmann et al., 1996; 
Prokhorova et al., 1994; Fathi et al., 2001). Although IMϕs are poorly characterized 
compared with AMϕs, it is clear the two macrophage populations are distinct and play 
different roles in pulmonary immune responses. 
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1.4 Macrophage polarization 
Macrophages demonstrate remarkable plasticity as they can assume different 
functional phenotypic states in response to different environmental states. Typically, 
macrophages have been classified as being either M1 or M2, corresponding to the Th1 and 
Th2 paradigms seen in helper T cells (Mantovani et al., 2004; Hume 2015). The M1/M2 
concept originates from the differences observed in macrophage polarization between 
C56BL/6 (M1) and BALB/c (M2) mice due to differences in their gene expression profiles 
(Heinz et al., 2013; Raza et al., 2014; Wells et al., 2003). These differences may be due to 
differences in expression of transcription factor binding sites and/or DNA methylation 
patterns (Heinz et al., 2013; Schilling et al., 2009). The M1 phenotype marked by CD38 
produces pro-inflammatory cytokines including TNF-α to recruit other immune cells to the 
site of infection (Murugan & Peck, 2009; Jablonksi et al., 2015) Conversely, alternatively 
activated (M2) macrophages marked by mannose receptor (Mrc1) and CD83 secrete anti-
inflammatory cytokines such as transforming growth factor beta (TGF-β), IL-4, and IL-10 
to stimulate Th2 cytokine production and assist with the resolution of cell-mediated 
inflammation (Spellberg & Edwards, 2001; LaFlamme et al., 2012; Gao et al., 2015; 
Jablonski et al., 2015; Yamaguchi et al., 2015). In addition, Th2/M2 responses are found to 
be the dominant response in allergy, asthma, and parasite infections (Bønnelykke et al., 
2015; Chung 2015, Chávez-Galán et al., 2015).  
 
iNOS and arginase-1 
The regulation of arginine metabolism is critical for macrophage polarization. iNOS 
is an enzyme which converts arginine to NO and citrulline, and is considered to be a marker 
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of M1 phenotype. Upregulation of iNOS is an important component of the M1 phenotype, 
as secreted NO is a critical microbicidal molecule and can also be further metabolized to 
other reactive oxygen species such as peroxynitrite (Ignarro 1990; Italiani and Boraschi, 
2014). Furthermore, NO can nitrosylate proteins which may in turn alter protein function 
(Rath et al., 2014). Additionally, it has been found that arginine concentrations decline to 
undetectable levels at inflammatory sites, highlighting the importance of selective arginine 
metabolism in regulating the M1/M2 response (Mills 2012).  
M2 polarization may be induced by cytokines secreted from Th2 cells including IL-
4 and IL-13 (Gordon 2003; Van Dyken and Locksley, 2013). These cytokines cause a shift 
in the arginine metabolism such that there is an increase in arginase-1 activity leading to L-
ornithine production which promotes proliferation and repair (Morris, 2007). L-ornithine 
may be decarboxylated to produce polyamines necessary for cell growth, protein translation, 
and differentiation, or it may be converted to proline increasing production of collagen which 
may be important for tissue remodelling (Hesse et al., 2001; Van Dyken & Locksley, 2013). 
Due to increased arginase-1 activity—and a relative decrease in iNOS activity—there are 
low levels of pro-inflammatory NO within the cell, and the macrophage will now release 
anti-inflammatory mediators including TGF-β and IL-10 (Lech & Anders, 2013). TGF-β 
appears to be important for maintenance of M2 phenotype within the system, as it may exert 
anti-inflammatory effects by further inhibiting NO production (Mills 2012).  
The M1/M2 paradigm demonstrates a balanced cellular system wherein upregulation 
of arginase-1 activity due to M2 phenotype will break down the substrate which M1-
associated iNOS requires to produce NO (Figure 1.1). However, the M1/M2 classification 
is a limited view of macrophage phenotypes. In reality macrophages alter their phenotype 
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along a continuum in order to produce typical M1/M2 responses, or anywhere between these 
two extremes (Stout et al., 2009). This ability for macrophages to adopt various phenotypes 
allows them to orchestrate the systemic immune response. Each phenotype has distinct 
cytokine secretion profile depending on their polarized state, which is influenced by signals 
in their microenvironment (Mosser and Edwards, 2008; Xue et al., 2014; Robbe et al., 2015).  
 
1.5 M1 polarization 
M1 polarization is the most prevalent monocyte and tissue macrophage type seen in 
classical inflammation (Robbe et al., 2015). The M1 polarization of macrophages can be 
initiated by pro-inflammatory cytokines released from Th lymphocytes, including IFNγ; or 
triggered by PAMPs from pathogens such as LPS. 
 
1.5.1 IFNγ and IFNGR 
The IFNγ receptor (IFNGR) is composed of two IFNGR1 chains responsible for 
ligand binding and signalling, and two IFNGR2 chains mainly associated with signal 
transduction (Schroder et al., 2004). While IFNGR1 expression is constitutively high, 
IFNGR2 limits the responsiveness of IFNγ as its expression is constitutively low and may 
be upregulated according to cellular activation state (Bernabei et al., 2001). IFNGR lack 
kinase activity, and therefore must associate with other proteins for receptor phosphorylation 
and consequent signal transduction. The intracellular domain of IFNGR1 expresses a Janus 
Kinase 1 (JAK1) binding site, as well as a signal transducer and activator of transcription 1 
(STAT1) docking site which must be phosphorylated prior to association. IFNGR2 is 
associated with JAK2 (Bach et al., 1997). Typical IFNγ signalling occurs via the  
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Figure 1.1. Arginine metabolism pathways. Adapted from Rath et al., 2014. iNOS and 
Arginase-1 are prominent markers of the M1 and M2 phenotype, respectively. iNOS 
metabolizes arginine to NO and citrulline. NO, as well as its metabolite peroxynitrite, 
possess microbicidal function, while citrulline may be converted back to arginine for 
further metabolism. Arginase-1 primarily converts arginine to ornithine. Ornithine is 
further converted to polyamines by ornithine decarboxylase (ODC) and proline by 
ornithine aminotransferase (OAC), important for promotion of proliferation and tissue 
repair. 
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JAK/STAT1 signalling pathway. Upon ligand binding to the IFNGR1, JAK1 and JAK2 are 
activated and can then phosphorylate INFGR1 (Stark, 2007). Following phosphorylation, 
unphosphorylated STAT1 dimers located in the cytoplasm may associate with the receptor. 
Once associated STAT1 is phosphorylated which allows for its translocation to the nucleus 
where it stimulates target genes (Hu & Ivashkiv, 2009). The IFNγ/STAT1 pathway is 
primarily responsible for the induction of iNOS expression, pro-inflammatory cytokine 
secretion, as well as chemokines including C-X-C ligand motif (CXCL) 9, CXCL10 and 
CXCL11 which attract natural killer and T cells to assist in the inflammatory response 
(Martinez et al., 2008; Trinchieri 2003; MacMicking et al., 1997). 
  Many immune cells have the capacity to produce and secrete IFNγ, including Th1 
cells, natural killer cells, and professional antigen-presenting cells including macrophages 
(Young, 1996; Frucht et al., 2001). Macrophage release of IFNγ may be a key component of 
early inflammatory responses, likely involved in autocrine activation as well as paracrine 
activation of nearby immune cells (Gessani & Belardelli, 1998; Frucht et al., 2001). IFNγ 
has been shown to inhibit proliferation of Th2 cells without affecting Th1 cell proliferation. 
As a result, the T-lymphocyte population shifts towards the pro-inflammatory Th1 state 
(Bach et al., 1995). Furthermore, IFNγ causes increased cell surface expression of class I 
MHC on macrophages which effectively increases the likelihood for cytotoxic T cell 
recognition of non-self peptides and subsequent cell-mediated immunity (Boehm et al., 
1997). Exposure to IFNγ has been shown to result in upregulation of iNOS and shift the 
cellular priorities away from proliferation and towards effector functions including the 
production and secretion of pro-inflammatory cytokines, and synthesis of NO and other 
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reactive oxygen species in order to kill invading microbes (Schroeder et al., 2004, van Dyken 
and Locksley, 2013; Fairfax et al., 2014; Hume & Freeman, 2014) 
 
1.5.2 LPS and TLR4 
LPS, a component of gram-negative bacterial cell wall, is a PAMP and thus its 
molecular structure and receptor are well studied. LPS consists of three parts: lipid A, an 
oligosaccharide core, and a highly variable O side chain (Raetz & Whitfield, 2002; Miller et 
al., 2005). The main PAMP of LPS is lipid A which has been highly conserved throughout 
evolution (Płóciennikowska et al., 2015). TLRs are a group of PRRs expressed by cells of 
the innate immune system, which respond to structural motifs known as PAMPs (Akira et 
al, 2006). Thirteen different types of TLRs have been identified in mammals, twelve of 
which are found in mice and ten in humans (Płóciennikowska et al., 2015). TLR4 is an 
essential PRR which recognizes LPS and begins a downstream cascade to initiate an 
inflammatory response (Kawai and Akira, 2010; West et al., 2006, Beutler, 2009). A 
sequence of molecular interactions must take place before LPS elicits a response from TLR4. 
First LPS must bind to LPS binding protein, a soluble shuttle protein which facilitates the 
association between LPS and CD14, a glycosylphosphatidylinositol-anchored glycoprotein 
found on the cell surface of macrophages (Wright et al., 1989; Simmons et al., 1989; Lu et 
al., 2008). The primary binding site for LPS is located in an N-terminal hydrophobic pocket 
of CD14 monomers (Kim et al., 2005; Kelley et al., 2013). Next CD14 transfers LPS to MD-
2, a soluble protein which is associated with TLR4 (Nagai et al., 2002; Gioannini et al., 
2004). By interacting with MD-2 and the adjacent TLR4 simultaneously, LPS promotes 
dimerization with a second MD-2/TLR4 receptor complex (Park et al., 2009). Following 
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oligomerization, four adapter proteins including myeloid differentiation primary response 
gene 88 (MyD88), Toll/interleukin-1 receptor domain-containing adaptor protein (TIRAP), 
TIR domain-containing adaptor inducing IFN-β (TRIF), and TRIF-related adaptor molecule 
(TRAM), are recruited through interactions with TIR domains (O’Neill & Bowie, 2007). 
LPS engagement of TLR4 can initiate signalling via both MyD88-dependent and MyD88-
independent pathways. 
MyD88-dependent signalling involves MyD88 and TIRAP. Following TLR4 
activation, MyD88 recruits IL-1 receptor-associated kinase-4 and inducing a protein 
phosphorylation cascade ultimately resulting in activation of IκB kinase (IKK) (Motshwene 
et al., 2009; Lin et al., 2010b; Gay et al., 2014). IKK phosphorylates inhibitor of κ light chain 
gene enhancer in B cells (IκB), resulting in degradation of inhibitory IκB proteins and 
consequent translocation of nuclear factor kappa-light-chain-enhancer of activated B cells 
(NF-κB) to the nucleus (Lu et al., 2008). Mitogen-activated protein kinase pathways 
extracellular signal-regulated kinase, p38, and c-Jun N-terminal kinase are also activated 
downstream of TLR4, all of which also play a critical role in the secretion of pro-
inflammatory cytokines (Sato et al., 2005; Peroval et al., 2013).  
MyD88-independent signalling functions through adapter protein TRAM and 
signalling molecule TRIF. TRIF recruits another adapter protein (TRAF3) to activate 
interferon regulatory factor 3 resulting in induction of type I interferon genes as well as IFN 
inducible chemokines such as IL-10 (Oganesyan et al., 2006; Kawai & Akira, 2011). TRIF 
also recruits and activates IKK leading to NF-κB activation (Meylan et al., 2004; Ea et al., 
2006). Macrophage interaction with various types of bacteria and viruses induces 
transcription of many pro-inflammatory genes associated with the M1 phenotype, including 
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TNF-α, IL-6, and iNOS (Benoit et al., 2008). This response consequently stimulates Th1 cell 
population expansion and release of IFNγ. However, some studies demonstrate that TLR 
signalling, when accompanied by ligation of Fc gamma receptor (FCγR) results in M2b 
phenotype that is characterized by arginase-1 upregulation along with TNF-α and IL-10 
secretion (Anderson et al., 2002). These macrophages are considered to be inhibitors of the 
acute inflammatory response due to their large secretion of IL-10, which can stimulate Th2 
cell proliferation and secretion of IL-4/IL-13 (Martinez et al. 2008). Macrophage phenotypic 
polarizations are not mutually exclusive. A recent study examining AMϕ response to 
influenza virus demonstrated the AMϕs polarize to the M1 phenotype by 4 hours post-
infection, and shift to M2b phenotype by 8 hours post-infection (Zhao et al., 2014). These 
findings highlight the plasticity of macrophage populations, not only in response to different 
stimuli but also over time with the same stimuli. 
 
1.6 M2 polarization 
     Macrophages also take part in inflammation resolution and tissue repair, a highly 
organized process which reverses the inflammatory response by induction of counter-
regulatory mechanisms, including halting neutrophil recruitment, as well as removal of 
apoptotic neutrophils. In a model of LPS induced lung injury it has been demonstrated that 
exudate macrophages derived from GR-1high CCR2high CX3CR1low monocytes release IL-1 
receptor antagonist (IL-1ra), which may block activity of IL-1 receptor (IL-1R) on AMϕs 
and alveolar epithelial cells (Benoit et al., 2008; Hussel & Bell., 2014). As a result of IL-1R 
antagonism, the release of macrophage inflammatory protein 2 by AMϕs and alveolar 
epithelial cells decreases, effectively reducing neutrophil recruitment, but triggering 
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neutrophil apoptosis (Herold et al., 2011). It is proposed that upon recognition of apoptotic 
neutrophils the pro-inflammatory transcriptional profiles within the AMϕs are switched, 
wherein pro-inflammatory cytokine secretion decreases as a result of decreasing NF-κB 
stimulation (Cvetanovic and Ucker, 2004).  
M2 phenotype AMϕs are heterogenous, and they may be further described by three 
specific and distinct phenotypes: M2a, M2b, and M2c. The M2a subtype is the phenotype 
which is traditionally referred to simply as M2 or alternatively activated macrophages. 
Macrophages polarize to the M2a phenotype in response to IL-4/IL-13 and exhibit 
upregulated arginase-1, Ym1, FIZZ1, and secrete IL-10, and TGF-β (Rőszer, 2015). These 
macrophages are important for anti-inflammatory properties including cell proliferation, 
growth factor release, and apoptotic cell removal (Gensel & Zhang, 2015). M2b 
macrophages are often referred to as type II macrophages and are activated by TLR ligands 
including LPS and may secrete pro-inflammatory cytokines IL-6 and TNF-α. Studies suggest 
that M2b is of particular importance in the proliferative phase of inflammation resolution in 
order to trigger tissue remodelling (Mosser and Edwards 2008; Lech and Anders, 2013). 
M2b macrophages also release IL-10 which may potentially play a role in activation of M2c 
macrophages, which are primarily activated by IL-10 and TGF-β (Mantovani et al., 2004; 
Novak and Koh, 2013; Rőszer 2015). M2c macrophages are highly immunosuppressive and 
are found in higher quantities during the remodeling phase of inflammation resolution, as 
indicated by high levels of TGF-β (Lech and Anders, 2013; Novak and Koh, 2013).  
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1.6.1 IL-4 and IL-13 receptors 
IL-4 and IL-13 are both typical Th2 cytokines and can induce similar physiological 
effects. However, they are independently regulated and have distinct functions in a Th2/M2 
response. In macrophages IL-4 and IL-13 can elicit a myriad of cellular responses by 
interacting with two types of heterodimeric transmembrane receptor complexes. The type I 
receptor is composed of an IL-4Rα chain paired with a common gamma (γC) chain, whereas 
the type II receptor results from the pairing of the IL4-Rα chain with an IL-13Rα1 chain 
(Munitz et al., 2008). Consequently, only IL-4 may activate the type I receptor, but both IL-
4 and IL-13 are capable of binding type II receptors. Both receptor types mediate their 
signalling responses via JAK-STAT pathways: IL-4Rα is associated with JAK1, γC 
associates with JAK3, and IL-13Rα1 with JAK2 (Kelley-Welch et al., 2003; Heller et al., 
2012). There is also a decoy receptor IL-13Rα2 for which IL-13 has four orders of magnitude 
greater binding affinity than IL-13Rα1, however this receptor does not interact with a JAK 
and is generally considered to be indirectly inhibitory (Lupardus et al., 2010; Madala et al., 
2011; Heller et al., 2012). The shared IL4-Rα chain stimulates JAK1 which activates STAT6, 
a key component of IL-4/IL-13-mediated upregulation of arginase-1 and downregulation of 
NO production (Rutschman et al., 2001). In macrophages, the type I receptor also exhibits 
γC dependent tyrosine phosphorylation of insulin receptor substrate 2, which can recruit 
phosphoinositide 3-kinase and consequently lead to upregulated expression of several M2-
related genes including arginase-1, and Ym1 (Heller et al., 2008). 
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1.6.2 IL-4/IL-13 downstream signalling  
One established action of IL-4 in tissue resident macrophages is to increase 
proliferation (Jenkins et al., 2011). Activated STAT6 translocates to the nucleus where it 
upregulates/activates transcription of several target genes, one being stem cell-inducing 
factor Krüppel-like factor 4 (KLF4), an important factor in macrophage self-renewal and 
development (Aziz et al., 2009). KLF4 has also been noted to co-operate with STAT6 to 
upregulate arginase-1 along with Mrc1, and resistin-like molecule (Retnla/FIZZ1) alpha, all 
of which are hallmarks of the M2 phenotype (Liao et al., 2011). Simultaneously KLF4 has 
been shown to actively suppress M1-associated NF-κB activation (Liao et al., 2011; Pello et 
al., 2012). Both IL-4 and IL-13 appear to activate peroxisome proliferator-activated receptor 
gamma and delta via STAT6, leading to suppression of inflammation (Odegaard et al., 2007; 
Odegaard et al., 2008; Kang et al., 2008). Despite these discoveries made in various cell 
types, the specific role of IL-4/IL-13 and their respective receptors have not yet been fully 
elucidated in AMϕs. 
 
1.7 GABA signalling in macrophages 
1.7.1 GABA synthesis, release and uptake 
Gamma-aminobutyric acid (GABA) is the primary inhibitory neurotransmitter in the 
central nervous system (Sieghart, 2006). Therefore, knowledge of GABA signalling is 
obtained mainly from studies of neuronal cells. GABA is produced by decarboxylation of L-
glutamate through the enzymatic activity of glutamic acid decarboxylase (GAD), which has 
two different isoforms: GAD65 and GAD67 (Nasreen et al., 2011). In neurons GAD65 is 
localized to the nerve terminals and is involved with GABA synthesis for neurotransmission 
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(Soghomonian & Martin, 1998). Vesicular GABA transporter (GAT) transports GAD65-
produced GABA into secretory vesicles until release (McIntire et al., 1997). GAD67 is 
distributed throughout the cell body and synthesizes GABA for development and normal cell 
function (Kanaani et al., 2010). Murine knockout studies have demonstrated the importance 
of GADs, specifically GAD67, in development. Fetuses lacking GAD67 may perish from 
respiratory failure, and possess abnormalities in axonal and synaptic morphogenesis making 
the organism unviable (Kuwana et al., 2003, Salazar et al., 2008). GABA transaminase 
(GABA-T) is an enzyme which functions to degrade GABA and convert it back into L-
glutamate, balancing glutamate-GABA metabolism (Bhat et al., 2010, Liu et al., 2004).  
  After GABA has generated its signalling effects it must be removed from the 
extracellular environment by the GAT in order to limit signalling duration. There are four 
types of GATs (GAT1–4), and their activity is Na+/Cl- dependent (Salazar et al., 2008). 
GAT-1 is primarily responsible for GABA uptake in the adult central nervous system (Gadea 
& Lopez-Colome, 2001; Schousboe et al,. 2004), however GAT-3 is most prevalent during 
development (Evans et al., 1996; Minelli et al., 2003).  
 
1.7.2 GABA receptors 
GABA generates signals through ionotropic A-type and C-type receptors, as well as 
metabotropic B-type receptors (Möhler, 2006; Benarroch, 2007; Lujan, 2007). GABAARs 
are GABA-gated ion channels that are permeable to anions such as chloride. A functional 
GABAAR is composed of five subunits and each GABAAR subunit has four transmembrane 
domains (M1-M4), as well as a large extracellular N-terminal domain and a short 
intracellular C-terminal domain (Barnard et al., 1998; Sigel & Steinmann, 2012).  Humans 
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express a myriad of genes which may code for the following GABA receptor subunits: α1–
6, β1–3, γ1–3, δ, ε, θ, and π (Simon et al., 2004). While a variety of subunits may be used to 
form the GABA receptor, most physiologically relevant receptor compositions are formed 
by two α, two β, and one other subunit which is most frequently γ. (Sigel & Steinmann, 
2012). As a result, GABAARs may achieve functional diversity by variations in subunit 
combinations, affecting factors such as affinity for GABA, or ion channel kinetics, which 
will alter the result of GABA binding (Macdonald & Olsen, 1994; Benarroch, 2007). Subunit 
composition also has important pharmacological consequences; as different subunit 
compositions may affect the degree to which GABAergic drugs such as benzodiazepines 
open the receptor pore.  For example, zolpidem shows preferential affinity for the α1 subunit 
and has hypnotic effects, while diazepam exerts its anxiolytic effects through GABAARs 
which express α2 (Crestani et al., 2000; Crestani et al., 2001; Möhler, 2006). Gephyrin is a 
scaffolding protein for GABAARs. In neurons, gephyrin interacts with GABAAR subunits 
and helps to anchor and cluster receptors at inhibitory synapses (Choii & Ko, 2015).  
GABAARs are ligand gated ion channels, which upon activation by the endogenous 
ligand GABA results in Cl- flow through the channel in the direction determined by 
electrochemical gradient (Sieghart, 2006). In typical neurons Cl- flows inward resulting in 
hyperpolarization of the cell. However, in premature neurons it has been found by patch 
clamp recording that Cl- flow is outward resulting in cellular depolarization (Bhat et al., 
2010; Ben-Ari Y et al., 2007). The direction of Cl- flow has been determined to be a result 
of variations in intracellular Cl- concentration. Immature neurons have intracellular 
concentration of Cl- of roughly 30mM, whereas the Cl- concentration in mature neurons is 
closer to 10mM. As a result, GABAAR binding causes efflux in neuroblasts, and influx in 
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mature neurons (Owens et al., 1996). Elevated Cl- in premature neurons can be attributed to 
NKCC1, a Na+/K+/2Cl- active symporter, which results in intracellular accumulation of Cl-. 
This effect is balanced in matured neurons by the K+/Cl- co-transporter KCC2, which pumps 
Cl- out of the cell (Owens & Kriegstein, 2002). This process has also been hypothesized to 
occur in immune cells (Tian et al., 2004; Prud’homme et al., 2015). 
GABACRs are GABA-gated pentameric anionic channels that are composed of 
subunits ρ1–3.  Similar to GABAARs they can be inhibited by treatment with picrotoxin and 
activated by muscimol, however these receptors do not respond to bicuculline (Bormann & 
Feigenspan, 1995; Feigenspan & Bormann, 1998). Pharmacological differences between 
GABAAR and GABACR are not fully understood, however, ρ1 subunit of GABACR is highly 
expressed in both the olfactory bulb and the retina, implicating a potential role for GABAC 
signalling in these systems (Cutting et al., 1991; Chen et al., 2007).  
GABABR is a G-protein coupled receptor (GPCR), a large protein family which bind 
ligands outside the cell and activate signal transduction pathways by coupling with specific 
G proteins (Trzakowski et al., 2012). A functional GABABR is formed by two subunits, 
GABAB1 and GABAB2. In the brain the GABABR are most commonly linked via G proteins 
to open K+ channels in order to hyperpolarize neurons (Chen et al., 2005). In addition, 
GABABR suppresses voltage-gated Ca
2+ channels effectively decreasing Ca2+ entry 
(MacDermott et al., 1999).  
 
1.7.3 GABAAR signalling in neural development  
GABA signalling has been hypothesized to play an important role during 
neurogenesis, affecting proliferation, differentiation, and migration (Owens & Kriegstein, 
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2002; Ben-Ari, 2002). During the developmental stages the GABA-mediated inhibitory 
effect is not present. Instead, activation of GABAARs in developing neuroblasts results in a 
depolarizing effect due to Cl- efflux. This depolarization has been shown to inhibit DNA 
synthesis and arrest the cell cycle, effectively preventing proliferation which may initiate a 
shift towards differentiation (LoTurco et al., 1995; Estefanía et. al, 2012). For example, a 
study by Tozuka et al., shows that treatment of brain slices with GABA increases expression 
of NeuroD, a transcription factor that contributes to neuronal differentiation (Tozuka et al., 
2005). Since GABA signalling is critical for development and differentiation in the brain, it 
is possible that GABA signalling may also influence phenotypic shift in other cell types.  
 
1.7.4 GABA signalling in immune cells 
Recent research has demonstrated the presence and activity of GABA signalling 
within the peripheral system, including the pancreas and immune system (Bhat et al., 2010; 
Taneera et al., 2012). GABAAR subunits α1, α2, β3 and δ have also been discovered in 
murine peritoneal macrophages (Reyes-García et al., 2007). Furthermore, recent research 
has demonstrated the presence of GABAAR on human AMs (Sanders et al., 2015). There are 
several noted functions for GABAARs in the immune system, including immunosuppression. 
Prud’homme et al., demonstrated GABA signalling in T cells and macrophages resulted in 
a decrease of pro-inflammatory cytokine secretion via NF-kB inhibition (Prud’homme et al., 
2013). Peritoneal macrophages isolated from mice and treated with GABA-T inhibitor 
vigabatrin secreted significantly lower quantities of pro-inflammatory cytokine IL-1β 
following LPS stimulation (Bhat et al. 2010). GAT2 expression and consequently GABA 
uptake has been found to be upregulated following inflammatory activation (Dionisio et al., 
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2011, Paul et al., 2014). Taken together, these findings illustrate the inflammation 
suppression due to GABA signalling, and the inflammatory response that occurs when the 
signalling is interrupted. GABA is also reported to contribute to increased proliferation in 
response to endogenous GABA or by treatment with GABAAR selective agonist muscimol 
(Takehara et al., 2007; Tamayama T et al., 2005).  
 
1.8 GABA signalling in AMϕs – Preliminary data 
Unpublished studies in my laboratory using lys-EGFP-ki mice (Faust et al., 2000) 
have demonstrated the presence of α2-GABAAR on AMϕs in murine lungs, of which the 
expression decreases when the animal is injected peritoneally with LPS (Figure 1.2). 
Conversely in an ovalbumin (OVA)-induced asthma model, the α2-GABAAR expression in 
AMϕs increases in comparison with controls (Figure 1.3). These findings suggest a link 
between GABA signalling and AMϕ polarization. Therefore, I began to explore whether 
GABAAR-mediated signalling plays a role in AMϕ polarization when carrying out an honors 
thesis project. My studies demonstrated that under culture conditions AMϕs extracted from 
bronchoalveolar lavage (BAL) expressed high levels of α2- and β2/3-subunits of GABAAR, 
as well as GAD65/67 (Figure 1.4).  
When these AMϕs were treated with LPS, the expression of α2-GABAAR decreased 
drastically while the expression of F4/80, an immunoregulatory GPCR in mouse 
macrophages (Lin et al., 2010a), increased significantly (Figure 1.5). Treatment of the 
primary AMϕs with the GABAAR channel blocker picrotoxin increased TNF-α secretion 
suggesting that an autocrine GABA signalling in AMϕs critically regulates the cells’ 
function Interestingly, following LPS treatment picrotoxin no longer affected TNF-α  
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Figure 1.2. GABAAR expression is decreased following LPS treatment. (A) Lung tissues 
prepared from naïve (Control) lys-EGFP-ki mice (Faust et al., 2000) and lys-EGFP-ki mice 
intraperitoneally injected with LPS (100 μg/kg) were immune-stained for α2-subunit of 
GABAAR (red). Twenty-four hours after LPS treatment, a large number of macrophages 
infiltrated the lung, which express both GFP and α2-GABAAR. (B) Plotting data from image 
analyses showed that the immunofluorescent intensity of α2-GABAAR in AMϕs of LPS-
treated mice significantly decreased, in comparison with control mice. Plotted data represent 
mean ± SEM.  Significant difference (unpaired T-test), p < 0.01 (**). 
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Figure 1.3. GABAAR expression is increased in OVA-treated mice. BALB/c mice were 
sensitized twice at day-1 and day-11 and then challenged at day-30 with ovalbumin (OVA) 
to induce allergic asthmatic reaction, an immune response characterized by Th2 
inflammation (Singh et al., 2011). (A) Lung tissues of naive mice (control) and OVA-treated 
mice were double-strained for α2-subunit of GABAARs (red) and DAPI (blue). AMϕs and 
alveolar type II epithelial cells were indicated with yellow arrows and green arrows, 
respectively. (B) The immunofluorescence intensity of α2-GABAAR increased significantly 
in AMϕs of OVA-treated mice, in comparison with control mice. Plotted data represent mean 
± SEM.  Significant difference (unpaired T-test), p < 0.01 (**). 
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Figure 1.4. AMϕs express GABA signalling molecules. AMϕs were isolated by BAL of 
C57BL/6 mice. Immunocytochemical assays showed that AMϕs express GAD65/67, as 
well as the α2- and β2/3-subunits of GABAAR.  
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Figure 1.5. Activation of murine AMϕs with LPS reduces GABAAR expression. (A) 
AMs extracted from BAL of C57BL/6 mice were treated with LPS (500ng/mL) for 16 hours. 
Naïve (control) and LPS-treated (+ LPS) cells were then double-stained for F4/80 (red) and 
α2-GABAAR (green). (B) Plotted data showed that LPS treatment largely increased the 
immunofluorescence of F4/80 (B2), indicating an activation of AMϕs, but decreased the 
immunofluorescence of α2-GABAAR (B1). Plotted data represent mean ± SEM.  Significant 
difference (unpaired T-test), p < 0.05 (*), n = 3. 
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Figure 1.6. GABAAR blockade increased TNF-α secretion from control, but not LPS-
treated AMϕs. (A). ELISA of culture media revealed that treating AMϕ with GABAAR 
antagonist picrotoxin (PIC, 50µM), but not GABA (100 µM), for 24 hours significantly 
increased TNF-α secretion, suggesting an autocrine GABA signalling of the cells. (B). 
Treating AMϕs with LPS (500ng/mL) for 24 hours greatly increased TNF-α secretion. 
However, treating the cells with LPS and GABA (L + G), or with LPS and picrotoxin (L + 
P) for 24 hours had no significant effect on TNF-α secretion. Plotted data represent mean ± 
SEM.  Significant difference (ANOVA/Tukey’s HSD), p < 0.05 (*), p < 0.0001, n = 3. 
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secretion, which may be related to the downregulation GABAARs by LPS (Figure 1.6). 
 
1.9 Rationale, hypothesis, and aims 
1.9.1 Rationale 
  AMϕs are unique tissue resident macrophages due to their direct exposure to the 
atmosphere. Over the course of an immune challenge to the lung, LMϕs—including AMϕs—
play a pivotal role in both the inflammatory process and resolving inflammation. More 
precisely, LMϕs respond to stimuli present in their environment by polarizing to different 
phenotypes in order to maintain the homeostasis of lung tissues. Therefore, a tight regulation 
of phenotypic populations of LMϕs within the lung is critical for pulmonary immunity. Like 
other tissue resident macrophages, LMϕs express higher levels of iNOS when exhibiting an 
M1 phenotype, but express high levels of arginase-1 when polarizing to M2 phenotypes.  
 Previous studies in my laboratory demonstrated expressions of GAD65/67 and 
GABAARs in LMϕs. Interestingly the expression levels of GABAARs in LMϕs, particularly 
in AMϕs, decreased in mice treated with LPS but increased in mice experiencing allergic 
asthmatic reaction. My 4th year honors thesis studies confirmed the expression of GAD65/67 
and GABAARs in AMϕs under culture conditions, and the GABAAR expression decreased 
in cultured AMϕs 24 hours after exposure to LPS. Importantly, blocking GABAAR-mediated 
signalling in control AMϕs increased TNF-α secretion. Taken together, these combined 
results from previous studies suggested that an autocrine GABA signalling plays a role in 
phenotypic polarization of AMϕs. Although GABA signalling has been identified in other 
immune cells such as peritoneal macrophages, very little study on GABA signalling has been 
done in either AMϕs or IMϕs.  In particular, whether GABA signalling regulates LMϕ 
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polarization remains to be addressed. This thesis study sought to determine if GABA 
signalling in LMϕs regulates their phenotypic polarization as well as inflammatory 
response. 
 
1.9.2 Hypothesis 
  On the basis of available data, I hypothesized that GABA signalling regulates 
phenotypic polarization and inflammatory activities of LMϕs. 
 
1.9.3 Aims 
To test the above hypothesis, I carried out experiments focused on the following two 
aims: 
 
The first aim was to determine if GABA signalling plays a role in LMϕ 
polarization. To this end, I first established specific markers for each phenotype of LMϕs. 
I expected to confirm that treating macrophages with LPS and Th1/Th2 cytokines alter their 
expression profiles of the conventional M1 and M2 markers iNOS and arginase-1, 
respectively. Along with specific markers, I also examined secretion of pro-inflammatory 
cytokine TNF-α and anti-inflammatory cytokines IL-4 and IL-10. I would then be able to 
examine the effects of GABAAR agonist and/or antagonist on the expression of these M1 
and M2 markers and cytokines. 
The second aim was to study whether the expression levels of GABA signalling 
proteins in LMϕs are modified with their phenotypic polarizations. More precisely, I 
determined whether the expression of GAD65/67 and α2-GABAAR in macrophages 
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changes during M1/M2 polarization, and if so, whether the phenotypic markers and cytokine 
profiles reflect the changes of GAD65/67 and α2-GABAAR expressions in the cells.  
Considering that quantification of phenotypic marker proteins would requires a large 
amount of cells but the quantity of LMϕs extracted from lung tissues was limited, I decided 
to use both primary LMϕs derived from C57BL/6 mice, as well as RAW 264.7 cells in my 
studies. RAW 264.7 cells are a macrophage cell line derived from BALB/c mice. These cells 
are widely used for studies as they maintain many of the properties of macrophages including 
NO production, motility, phagocytosis, and extreme sensitivity to TLR agonists. 
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2.0 MATERIALS AND METHODS  
 
Usage of animals in this study was approved by the UWO Animal Care and 
Veterinary Services through the Animal Use Protocols #2010-038 (Dr. Wei-Yang Lu) and 
#2016-010 (Drs. Sanjay Mehta and Sean Gill) 
 
2.1 RAW 264.7 cell culture 
 
RAW 264.7 cells (ATCC, Manassas VA) were cultured in Dulbecco’s Modified 
Eagle Medium (Gibco by Life Technologies) high glucose media containing 5.0 g/L L-
Glutamine, Fetal Bovine Serum (10%; Life Technologies) and Penicillin-Streptomycin 
(100U/100µg/mL; Life Technologies). Cells were incubated at 37°C; 5% CO2 and 95% O2. 
Cell were maintained and used before they reached 60-70% confluency. 
 
2.2 AM isolation and culture 
  Primary AMϕs were obtained from male C57BL/6 mice (8-10 weeks; Charles River 
Laboratories) by collecting bronchial alveolar lavage (BAL), of which it is estimated that 
98% of the cells retrieved are macrophages and only 0.2% will be IMϕs (Huang et al., 2005; 
Bedoret et al., 2009). Mice were anaesthetized using 1 – chloro – 2, 2, 2 – trifluoroethyl 
difluoromethyl ether (Isofluorane; Baxter Corporation), and euthanized by laceration of the 
inferior vena cava. A small incision was made in the trachea into which a catheter tube (BD 
Angiocath; Becton, Dickinson and Company) was inserted. One millilitre of lavage fluid—
1x Hanks Balanced Salt Solution (HBSS; CaCl2/MgCl2/MgSO4 free, Gibco by Life 
Technologies) containing 15mM ethylenediaminetetraacetic acid (EDTA; 0.5M, pH 8.0, 
Ambion by Life Technologies)—was pumped through the catheter into the lungs, and pulled 
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back out three times using a 1mL insulin syringe (0.45mm x 13mm; Becton, Dickinson and 
Company) in order to collect the cells. This process was repeated three times in order to 
maximize cell collection, yielding a total of 3mL of lavage fluid per mouse and roughly one 
million cells. 
After collection the cells in HBSS + EDTA were placed on ice until lavage of all 
mice was completed. The total lavage fluid was centrifuged at 1500rpm for 10 minutes at 
4°C. The cellular pellet was then washed two times in Dulbecco’s Phosphate Buffered Saline 
(PBS; CaCl2/MgCl2 free, Sigma Life Science), and the cell solution was centrifuged at 
1500rpm for 10 minutes at 4°C after each wash. The cells were re-suspended in AM Culture 
Media Roswell Park Memorial Institute Medium (RPMI; Gibco by Life Technologies) 1640 
medium containing Fetal Bovine Serum (10%; Life Technologies), L-glutamine (2mM; 
GlutaMAX 100x, Gibco by Life Technologies), and Penicillin-Streptomycin 
(100U/100µg/mL; Life Technologies). Cells were plated in 12-well plates on glass 
coverslips primed with Poly-D-Lysine and placed in a 37°C incubator containing 5% CO2 
and 95% O2. 
 
2.3 LMϕ isolation and culture 
LMϕs were obtained courtesy of Dr. Sean Gill and with the assistance of Cynthia 
Pape. Male C57BL/6 mice 12-14 weeks of age were euthanized and lungs were removed. 
The lungs were then perfused via the right ventricle with 10 mL PBS in order to remove red 
blood cells, and immediately placed in digest buffer (1X ‘S’ buffer + Enzyme D & Enzyme 
A; components of Lung Dissociation Kit, Miltenyi Biotec, Bergisch Gladbach, Germany). 
Tissue was then disrupted using Miltenyi’s gentleMACS dissociator, followed by a 30-
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minute incubation period. During this time the sample was subjected to continuous rotation 
using MACSmix Tube Rotator in order to allow for maximal enzymatic dissociation. The 
sample was disrupted once more, then passed subsequently through 100 and 70 µm cell 
strainers. Cells were then centrifuged at 1500 rpm for 10 minutes at 4°C and resuspended in 
RPMI 1640 + 0.5% bovine serum albumin + 2mM EDTA. Next, the sample was incubated 
at 4°C with Milentyi CD45+ microbeads for 15 minutes, which magnetically label the desired 
CD45+ cells. The solution containing cells and microbeads were added to LS columns 
attached to magnetic MidiMACS Separator. The column was then washed out with 3mL 
media, which eluted all cells except for CD45+ cells which were stuck to the magnetic 
microbeads. The column was removed from the magnetic separator and eluted resulting in 
the collection of only CD45+ cells, which were then used in immunocytochemical studies. 
The CD45 microbeads have been demonstrated to have high specificity as determined by 
flow cytometry, such that cells negative for CD45+ that are present in the original suspension 
do not flow through the column (Schiedlmeier et al., 2000).  
 
2.4 Cell treatments 
  Treatments used for both RAW 264.7 murine cell line and primary cells include: LPS 
(500 ng/mL; Sigma-Aldrich, St. Louis, MO), Th1 cytokine IFNγ (100ng/mL;Cedarlane, 
Burlington ON), Th2 cytokines IL-4 (25ng/mL; R&D Systems Inc., Minneapolis, MN) and 
IL-13 (25ng/mL; R&D Systems Inc.), GABAAR agonist muscimol (20μM; Sigma-Aldrich), 
GABAAR channel blocker picrotoxin (50μM; Sigma-Aldrich), iNOS inhibitor 1400W 
dihydrochloride (20µM; R&D Systems), and IKK inhibitor BAY 11-7082 (25μM;Santa 
Cruz Biotechnology Inc., Dallas, TX). Cells were treated with LPS, IFNγ, IL-4, and IL-13 
35 
 
 
for 16 hours, while inhibitors picrotoxin, 1400W dihydrochloride, and BAY 11-7082 were 
given 90 minutes prior to LPS or IL-4/IL-13 treatments.   
 
2.5 Western blot 
  Following treatment, cells were lysed and the protein concertation in lysate was 
determined using BioPhotometer Plus UV/Vis Photometer (Eppendorf, Hamburg, 
Germany). Western blotting was performed using an OwlTM dual-gel vertical electrophoresis 
system (Thermo Fisher Scientific, Waltham, MA). Resolving gels were selected for each 
protein of interest based on molecular weight. For detection of α2-GABAAR (50kD), and 
arginase-1 (38 kD) 10% acrylamide gels were run, while iNOS (131kD) was run on an 8% 
gel. GAD (65/67kD) was run on an 8% gel despite small protein size in order to allow for 
sufficient separation of the two proteins. A 4% stacking gel was used for all experiments. 
Through trial and error, appropriate loading protein concentrations were determined for each 
protein of interest: 80μg for GAD, 120μg for GABAAR, 70μg for arginase-1, and 60μg for 
iNOS. Samples were diluted in 2X sample buffer and electrophoresed in 192mM 
glycine/25mM Trizma base/0.1% SDS running buffer for 30 minutes at 60V, followed by 
one hour at 100V. Proteins were then transferred for two hours at 80V onto a 0.45μM 
nitrocellulose membrane (Bio-Rad laboratories, Mississauga, ON) using Mini Trans-Blot 
Cell (BioRad) containing 192mM glycine/25mM Trizma base/20% methanol transfer buffer. 
The membrane was then blocked for one hour in 5% skim milk in 10mM Tris-HCl/150mM 
NaCl/0.1% Tween-20 (TBS-T). Following the block, the membrane was probed overnight 
at 4°C with primary antibody against: α2-GABAAR (Rabbit; Alomone Labs Ltd., Jerusalem, 
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Israel), GAD 65/67 (Rabbit; Sigma-Aldrich), iNOS (Mouse, Santa Cruz Biotechnology), 
Arinase-1 (Chicken; Merck Millipore, Billerica, MA).  
The following day, the membrane was washed three times in TBS-T for 10 minutes 
followed by secondary antibody application for 1.5 hours. Secondary antibodies used were 
horseradish peroxidase-conjugated goat anti-rabbit immunoglobulin G (BioRad), goat anti-
mouse (Jackson ImmunoResearch Labs, West Grove, PA), and donkey anti-chicken 
(Jackson ImmunoResearch Labs). The membrane was washed three times for 10 minutes 
each. ClarityTM Western enhanced chemiluminesence Blotting Substrate (BioRad) was 
applied to the membrane for 5 minutes to allow for chemiluminescent imaging. Images were 
taken using Molecular Imager VersaDocTM MP 5000 System (BioRad, #1708650) in 
conjunction with Quantity One 1-D Analysis Software. Anti-β-actin (Mouse; Sigma-
Aldrich) antibody along with goat anti-mouse horseradish peroxidase (Jackson 
ImmunoResearch Labs) was used to detect β-actin as a loading control protein for all 
experiments. Image-J was used for densitometry analysis of Western blot images. Each 
experiment was repeated three times. 
 
2.6 Immunocytochemistry 
  Collected cells were seeded onto poly-D-Lysine coated glass coverslips in 12-well 
plates, then treated as outlined in Section 2.4. Once the media was removed, cells were fixed 
to the coverslip using a 4% paraformaldehyde (Electron Microscopy Science) solution 
diluted in PBS. Coverslips were then washed once with PBS containing 0.1M glycine, and 
twice more with PBS. At this point cells were permeabilized with 0.1% Triton X-100 
(Sigma-Aldrich), with the exception of studies examining α2- and β2/3-GABAAR 
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expression. Coverslips were then blocked with 5% Normal Donkey Serum (NDS; Jackson 
ImmunoResearch) diluted in PBS for 1 hour. The cells were treated overnight at 4°C using 
the following primary antibodies in 1% NDS solution: α2-GABAAR (Rabbit; Alomone Labs 
Ltd.), Arinase-1 (Chicken; Merck Millipore), F4/80 (Rat; Abcam, Cambridge, United 
Kingdom), GAD65/67 (Rabbit; Sigma-Aldrich), gephyrin (Mouse; Synaptic Systems, 
Göttingen, Germany) iNOS (Rabbit; Abcam), iNOS conjugated to Alexa Fluor 488 (Mouse, 
Santa Cruz Biotechnology Inc.), LAMP1 (Rat; R&D Systems), GAT-1 (Mouse; Synaptic 
Systems). 
  The next day coverslips were washed three times, then secondary antibody in 1% 
NDS was applied for one hour. The following secondary antibodies were purchased from 
Jackson ImmunoResearch for these studies: Alexa Fluor 488 Donkey Anti-Chicken, FITC 
Donkey Anti-Rabbit, FITC Donkey Anti-Rat, Cy3 Donkey Anti-Rat, Cy3 Donkey Anti-
Mouse, Cy3 Donkey Anti-Rabbit. Coverslips were washed three times, and 4′,6-Diamidino-
2-phenylindole dihydrochloride (DAPI; Sigma-Aldrich) was applied for 10 minutes in order 
to stain the nuclei. Finally, coverslips were mounted using Fluromount G (Electron 
Microscopy Sciences; Hatfield PA) and preserved until imaging. 
Cells were examined and photographed using the Zeiss LSM 510 Meta Confocal 
Microscope at the Confocal Microscopy Core Facility located at the Robarts Research 
Institute. Ten randomly selected cells were imaged from each treatment group, and each 
experiment was repeated three times. Image-J software was used for quantification of 
fluorescence intensity amongst test groups. For each cell in which staining intensity was to 
trace the perimeter of the cell was using Image-J, and the average staining intensity within 
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the enclosed area was calculated (Figure 2.1). After measurements of each cell were 
completed, the mean values were calculated for comparison between groups. 
 
2.7 Luminex assay 
Following treatment, the supernatant was removed and combined with Halt Protease 
Inhibitor Cocktail (Thermo Fisher Scientific) at a ratio of 1µL:100µL media, then 
centrifuged at 2000rpm for 10 minutes at 4°C. The cellular pellet was discarded and the 
supernatant was preserved at –80°C for Luminex multiplex assay. Cytokine analysis was 
carried out by Shannon Seney at the Screening Lab for Immune Disorders, Canadian Centre 
for Human Microbiome and Probiotic Research located at Lawson Health Research Institute 
in London, Ontario. Cell supernatants were tested via Luminex multiplex assay for TNF-α, 
IL-4, and IL-10. Luminex assays were carried out as follows: colour-coded beads were 
conjugated to protein-specific capture antibodies and added along with cell supernatant 
samples into a microplate and incubated for two hours. After washing the beads, protein-
specific, biotinylated detector antibodies were added and incubated with the beads for one 
hour. Excess biotinylated antibody was washed away, and phycoerythrin conjugated 
streptavidin was added to bind to biotinylated antibodies. After 30 minutes, the wells were 
washed to remove unbound streptavidin and the beads are analyzed with a dual-laser 
Luminex detection system. One laser analyzed which protein was being detected, while the 
other measured the intensity of the phycoerythrin signal, which is proportional to the protein 
concentration in the sample. 
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Figure 2.1. Illustration of delineating stained cells for immunofluorescence analysis. 
Images of immuno-stained macrophages were taken by confocal microscopy.  Using ImageJ, 
the perimeter of an individual cell in each image file was delineated allowing for analysis of 
the average intensity of immuno-stained protein in each cell. More than ten cells were 
measured from each treatment group. The calculated mean value of fluorescence intensity 
was plotted and compared between treatment groups. 
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2.8 Patch-clamp recording 
To test whether RAW264.7 cells produce and release GABA, we measured 
transmembrane current in cultured hippocampal neurons when exposing them to conditioned 
media from RAW264.7 cell cultures. Specifically, the conditioned media were collected 
from untreated RAW264.7 cells 24 hours after culture. Medium from the same bottle was 
incubated for 24 hours and then was used as controls. 
As described previously (Fortin et al., 2001), cortical neurons were cultured from 
dissociated cortices of E14.5 mice.  Briefly, cortices from C57BL/6 mouse embryos were 
dissected and incubated for 25 min at 37°C in Hank’s balanced salt solution (GIBCO, BRL) 
containing 0.50 mg/ml trypsin. Trypsinization was stopped by incubating with 0.2 mg/ml 
trypsin inhibitor and 0.2 mg/ml DNase I for 2 min at 25°C. Cells were triturated in 
Neurobasal medium (GIBCO) and the cell suspension was centrifuged, and then the pellet 
was re-suspended in Neurobasal medium containing B-27 supplement, N-2 supplement, 0.5 
mM glutamine, and 0.05 U/ml 0.05 mg/ml penicillin-streptomycin (GIBCO). Cortical cells 
were plated in Nunc 35 mm dishes coated with poly-D-lysine (Sigma-Aldrich). The cultured 
neurons were used for patch-clamp recordings 16 days after culture and they were bathed in 
the extracellular solution (ECS), which was composed of the following (in mM): 145 NaCl, 
1.3 CaCl2, 5.4 KCl, 25 HEPES, and 33 glucose, pH 7.4 (osmolarity, 315 mOsm).  
The procedures for whole-cell voltage-clamp recording were performed as 
previously described (Dong et al., 2004). Briefly, at room temperature (22°C) recordings 
were performed under voltage clamp (at -60 mV) mode with a MultiClamp 700 amplifier 
(Axon / Molecular Devices, San Francisco, CA). Electrodes (3-4 MΩ) were constructed from 
thin-walled glass (1.5 mm diameter; World Precision Instruments, Sarasota, FL). The 
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recording electrode was filled with an intracellular solution consisting of the following (in 
mM): 140 KCl, 35 KOH, 10 HEPES, 2 MgCl2, 1 CaCl2, 2 tetraethylammonium, and 4 ATP, 
pH 7.35 (osmolarity, 315 mOsm). Three to five minutes after a stable baseline recording was 
achieved, the control medium, conditioned medium, or medium containing 50 μM 
bicuculline was focally perfused to the test neuron, by means of a multibarrel perfusion 
system (SF-77B; Warner Instruments, Hamden, CT). The transmembrane conductance was 
continuously recorded, and the electrical signal was digitized, filtered (1 kHz), and acquired 
on-line using the program pClamp (Axon / Molecular Devices). 
 
2.9 Statistical analysis 
All graphs and statistics were produced using GraphPad Prism 6 software. Data are 
presented as mean values ± standard error of the mean. Statistical tests performed include 
non-parametric unpaired Student’s t-test, along with one-way ANOVA followed by either 
Dunnett’s or Tukey’s multiple comparisons test using a significance level of at least p < 0.05. 
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3.0 RESULTS 
3.1 Determining if GABA signalling plays a role in LMϕ polarization 
3.1.1 Blockade, but not stimulation, of GABAAR caused an opposite change in the 
expression of iNOS and arginase-1 in macrophages 
Typically, the M1 phenotype of macrophage is associated with elevated iNOS 
expression. My Western blotting assays determined that iNOS was undetectable in RAW 
264.7 cells under control culture. However, sixteen to twenty-four hours after treatment with 
IFNγ or LPS, a high level expression of iNOS was detected (Figures 3.1A and 3.1B), 
indicating the inducible expression nature of this enzyme as previously demonstrated 
(MacMicking et al., 1997; Italiani & Boraschi, 2014). Interestingly, treating RAW 264.7 
cells with LPS and the GABAAR antagonist picrotoxin further increased the expression level 
of iNOS by 2-fold (Figure 3.1B).  
Immunocytochemistry, in combination with confocal microscopy, revealed a low 
level of iNOS immunofluorescence in control LMϕs. Exposure of LMϕs to IFNγ, however, 
induced roughly a five-fold increase in fluorescent intensity of iNOS (Figure 3.1C). Treating 
the cells with IL-4 + IL-13, or IL-4 + IL-13 together with the GABAAR agonist muscimol 
did not affect the level of iNOS fluorescence. In contrast, treatment with IL-4 + IL-13 
together with picrotoxin yielded a significant 1.55-fold increase of iNOS-specific 
immunofluorescence (Figure 3.2).  
Western blot analysis showed that arginase-1 expression in RAW 264.7 cells at an 
unstimulated state was too low to detect (Figure 3.3). Commonly, macrophages polarizing 
to M2 phenotypes display an increased expression of arginase-1. Indeed, upon stimulation  
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Figure 3.1. Inducible expression of iNOS is increased by picrotoxin. RAW 264.7 cells 
were treated with IFNγ, LPS (500ng/mL), and picrotoxin (50μM). Both IFNγ (A) and LPS 
(B) induced iNOS expression following 16-hour treatment as determined by Western blot. 
Treatment with picrotoxin 90 minutes prior to LPS treatment further increased iNOS 
expression. (C) In primary LMϕs examined by immunocytochemistry and confocal 
microscopy, IFNγ (100ng/mL) strongly increased iNOS. Plotted data represent mean ± SEM 
Significant difference (ANOVA/Tukey’s HSD) p < 0.05 (*), p < 0.01 (**), n = 3. 
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Figure 3.2. Picrotoxin increases iNOS expression in LMϕs treated with Th2 cytokines. 
Primary LMs were treated with IL-4 (25ng/mL) + IL-13 (25ng/mL) for 16 hours. Neither 
IL-4 + IL-13 nor IL-4 + IL-13 + muscimol (20μM) had an effect on the immunofluorescent 
intensity of iNOS. Treatment with picrotoxin (50μM), however, resulted in a significant 
increase of iNOS intensity in IL-4 + IL-13 treated LMϕs. Plotted data represent mean ± 
SEM.  Significant difference (ANOVA/Dunnett’s test) p < 0.05 (*), n = 3. 
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Figure 3.3. Picrotoxin decreases arginase-1 expression in RAW 264.7 cells. Treating 
RAW 264.7 cells with IL-4 (25ng/mL) + IL-13 (25ng/mL) increased arginase-1 expression 
significantly. Adding the GABAAR agonist muscimol (20μM) to the culture had no effect 
on arginase-1 expression.  In contrast, the addition of GABAAR channel blocker picrotoxin 
(50µM) to the culture significantly decreased arginase-1 expression. Plotted data represent 
mean ± SEM.  Significant difference (ANOVA/Dunnett’s test) p < 0.01 (**), n = 3. 
 
 
 
 
 
 
 
 
46 
 
 
with Th2 cytokines IL-4 and IL-13, the protein level of arginase-1 was increased from 
relative density of 0 to 0.6. RAW 264.7 cells with the GABAAR agonist muscimol along 
with IL-4 and IL-13 did not appear to have an effect on arginase-1 expression. However, 
antagonizing GABAAR signalling with picrotoxin 90 minutes before IL-4 and IL-13 
treatment significantly hindered the extent to which these Th2 cytokines upregulated 
arginase-1, lowering relative density to 0.2 (Figure 3.3). In LMϕs, a low-level baseline-
expression of arginase-1 was detected by immunocytochemistry and confocal microscopy. 
Exposure of LMϕs to IFNγ effectively reduced the immunofluorescence intensity of 
arginase-1 (Figure 3.4). On the contrary, treating LMϕs with IL-4 and IL-13 increased the 
fluorescence intensity of arginase-1 by 1.35 fold. Notably, treating the cells with IL-4 and 
IL-13 and the GABAAR antagonist picrotoxin decreased arginase-1 levels, however in this 
instance arginase-1 was decreased below control expression levels (Figure 3.5). 
 
3.1.2 Blockade, but not stimulation, of GABAAR distinctively altered cytokine secretion 
from macrophages depending on their phenotypic polarizations 
 In order to further classify phenotypic polarizations induced by LPS, IFNγ, and IL-
4/IL-13 in the test macrophages, I employed the Luminex assay to analyze the concentrations 
of TNF-α, IL-10, and IL-4 in the media of RAW 264.7 cell and primary LMs. In addition, I 
applied muscimol and picrotoxin to examine the role of GABAAR-mediated signalling in 
regulation of macrophage cytokine secretion.  
  TNF-α Secretion: Analyses showed that treating RAW 264.7 cells with IFNγ or with 
LPS significantly increased TNF-α secretion in comparison with control by 1.7 and 2.25 
fold, respectively (Figure 3.6A).  
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Figure 3.4. IFNγ decreases arginase-1 in primary LMϕs. Primary LMϕs were treated with 
IFNγ (100ng/mL) resulting in a decrease in arginase-1 expression. Plotted data represent 
mean ± SEM.  Significant difference (unpaired T-test) p < 0.001 (***), n = 3. 
 
 
 
 
 
 
 
 
 
 
 
 
 
48 
 
 
Figure 3.5. Picrotoxin decreases arginase-1 expression in primary LMϕs. Primary LMϕs 
were treated with IL-4 (25ng/mL) + IL-13 (25ng/mL) resulting in increased arginase-1 
intensity. Adding muscimol (20μM) led to a slight decrease in arginase-1 expression 
compared with IL-4/IL-13 alone. Picrotoxin (50µM) pre-treatment decreased arginase-1 
staining intensity below control level. Plotted data represent mean ± SEM.  Significant 
difference (ANOVA/Dunnett’s test) p < 0.05 (*), n = 3. 
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Figure 3.6. LPS and IFNγ increase TNF-α secretion. (A) In RAW 264.7 cells, IFNγ 
(100ng/mL) and LPS (500ng/mL) both increase TNF-α secretion. (B) In primary LMϕs, 
IFNγ (100ng/mL) did not increase TNF-α secretion. LPS (500ng/mL) however, resulted in 
a large increase in TNF-α release. Plotted data represent mean ± SEM.  Significant difference 
(ANOVA/Tukeys’s test), p < 0.05 (*), p < 0.01 (**), p < 0.001 (***), n = 3. 
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However, in primary LMϕs, only LPS treatment yielded a nearly 3 fold increase in TNF-α 
(Figure 3.6B). On the other hand, treating RAW264.7 cells with IL-4 + IL-13 reduced TNF-
α secretion below control levels (Figure 3.7A). Addition of muscimol or picrotoxin did not 
have any impact on TNF-α secretion. In primary LMϕs IL-4 + IL-13 also reduced TNF-α 
secretion, however this effect was non-significant (Figure 3.7B). Once again, addition 
muscimol and picrotoxin did not affect secretion of TNF-α. 
IL-4 Secretion: Treatment with IFNγ and LPS induced a non-significant decrease of 
IL-4 secretion from RAW 264.7 cells (Figure 3.8A). However, both IFNγ and LPS resulted 
in a significant reduction of IL-4 secretion from LMϕs, with a more dramatic reduction 
following IFNγ treatment (Figure 3.8B). In contrast, treatment with IL-4/IL-13 greatly 
increased the detection of IL-4 in the media collected from both RAW 264.7 cells (Figure 
3.9A) and primary LMϕs (Figure 3.9B). Treating RAW 264.7 cells or LMϕs with muscimol 
did not change the IL-4/IL-13-induced increase of IL-4 secretion. Treating the LMϕs with 
IL-4/IL-13 and picrotoxin also had no significant effect on IL-4 detection (Figure 3.9B), 
however, this might have resulted from mistaken medium collection. Remarkably, treating 
RAW 264.7 cells with IL-4/IL-13 and picrotoxin significantly reduced the increase in IL-4 
secretion, in comparison with IL-4/IL-13 treatment alone.  
IL-10 Secretion: IFNγ did not increase IL-10 secretion in RAW 264.7 cells or LMϕs. 
Contrary to our expectations, however, IL-10 secretion was largely increased by LPS 
treatment in both RAW 264.7 cells and LMϕs (Figure 3.10A and 3.10B), suggesting that 
LPS treatment may have induced a non-M1 phenotype. More surprisingly, IL-4/IL-13 
significantly decreased IL-10 secretion from both RAW 264.7 cells (Figure 3.11A) and 
primary LMϕs (Figure 3.11B). IL-4/IL-13 + muscimol and/or picrotoxin had no effect. 
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Figure 3.7. IL-4 + IL-13 decrease TNF-α secretion. (A) In RAW 264.7 cells, IL-4 
(25ng/mL) + IL-13 (25ng/mL) caused a decrease in TNF-α release. Further addition of 
muscimol (20μM) or picrotoxin (50μM) did not further affect TNF-α secretion. (B) In 
primary LMϕs, IL-4 (25ng/mL) + IL-13 (25ng/mL) caused a slight but non-significant 
decrease in TNF-α secretion. Muscimol (20μM) or picrotoxin (50μM) did not have any 
effect. Plotted data represent mean ± SEM.  Significant difference (ANOVA/Dunnett’s test) 
p < 0.01 (**), n = 3. 
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Figure 3.8. LPS and IFNγ decrease IL-4 secretion. (A) In RAW 264.7 cells, IFNγ 
(100ng/mL) and LPS (500ng/mL) both decrease TNF-α secretion, though this change is not 
significant. (B) In primary LMϕs, LPS (500ng/mL) caused a modest decrease in IL-4 
secretion, while IFNγ (100ng/mL) nearly completely eliminated IL-4 secretion. Plotted data 
represent mean ± SEM.  Significant difference (ANOVA/Dunnett’s test) p < 0.05 (*), p < 
0.001 (***), n = 3. 
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Figure 3.9. IL-4 + IL-13 increase IL-4 secretion, which is inhibited by picrotoxin (A) In 
RAW 264.7 cells, IL-4 (25ng/mL) + IL-13 (25ng/mL) cause an increase in IL-4 secretion. 
Further addition of muscimol (20μM) did not affect IL-4 secretion, however pre-treatment 
with picrotoxin (50μM) inhibited IL-4 secretion. (B) In primary LMϕs, IL-4 (25ng/mL) + 
IL-13 (25ng/mL) caused a large increase of IL-4 release. Further addition of muscimol 
(20μM) or picrotoxin (50μM) had no effect. Plotted data represent mean ± SEM.  Significant 
difference (ANOVA/Tukey’s HSD) p < 0.01 (**), p < 0.001 (****), n = 3. 
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Figure 3.10. LPS increases IL-10 secretion. (A) Baseline secretion of IL-10 was minimal 
in RAW 264.7 cells, which was unaffected by treatment with IFNγ (100ng/mL). LPS 
(500ng/mL) induced a very large increase in IL-10 secretion, suggestive of M2b polarization. 
(B) In primary LMϕs, IFNγ (100ng/mL) treatment did not have an effect. However, LPS 
(500ng/mL) increased secretion of IL-10. Plotted data represent mean ± SEM.  Significant 
difference (ANOVA/Dunnett’s test) p < 0.05 (*), p < 0.0001 (****), n = 3. 
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Figure 3.11. IL-4 + IL-13 decrease secretion of IL-10 (A) In RAW 264.7 cells, IL-4 
(25ng/mL) + IL-13 (25ng/mL), IL-4 + IL-13 + muscimol (20μM), and IL-4 + IL-13 + 
picrotoxin (50μM) lowered IL-10 secretion, although these changes were not significant. (B) 
In primary LMϕs, IL-4 (25ng/mL) + IL-13 (25ng/mL) decreased secretion of IL-10, which 
decreased slightly further when muscimol (50μM) or picrotoxin (20μM) were added. Plotted 
data represent mean ± SEM.  Significant difference (ANOVA/Dunnett’s test) p < 0.05 (*), 
p < 0.01 (**), n = 3. 
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3.1.3 RAW 264.7 cells secrete GABA 
The results described above showed that blockade, but not stimulation, of GABAAR 
affected the expression levels of iNOS and arginase-1, as well as IL-4 production by 
macrophages under specific conditions.  Since both cell types express GABA-synthesizing 
enzyme GAD, I decided to examine whether these cells produce and secrete GABA. In 
collaboration with Matthew Maksoud, whole-cell voltage-clamp recordings were performed 
on cultured hippocampal neurons, which express GABAARs that contains subunits with high 
affinity to GABA (Caraiscos et al., 2004). It is known that GABAARs containing α5 
subunit(s) has high affinity to GABA. Exposure of hippocampal neurons to the conditioned 
media collected from untreated RAW264.7 cell cultures, but not the control (blank) media, 
resulted in a transmembrane current in 4 out of 6 test cells. The amplitude of the media- 
induced current varied from 26-128 pA. Notably the current induced by the conditioned 
medium was blocked by the competitive GABAAR antagonist bicuculline (Figure 3.12). 
These results indicated that under normal conditions RAW 264.7 cells produce and secrete 
GABA. 
 
3.2 Studying whether LMϕ polarization alters GABA signalling 
components 
3.2.1 IFNγ and LPS lowered expression of GABA signalling proteins 
 Next I investigated whether macrophage polarization was associated with changes in 
protein expressions of GAD65/67 and α2-GABAAR. Western blot assays showed that both 
α2-GABAAR (Figure 3.13A) and GAD65/67 (Figure 3.13B) were expressed in RAW 264.7 
cells. Sixteen hours after treatment with IFNγ and LPS, the expression levels of α2-GABAAR  
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Figure 3.12.  RAW 264.7 cell media induced bicuculline-sensitive transmembrane 
current in cultured hippocampal neurons. Shown are voltage-clamp recording traces in 
the same hippocampal neurons. Upper trace: exposing the cultured hippocampal neuron to 
conditioned media (RAW media), but not control (blank) media, induced a large 
transmembrane current. Lower trace: In the presence of 50μM bicuculline, a selective 
GABAAR antagonist, the conditioned media failed to induce current in the neuron. Note: 
Patch-clamp recording experiments were graciously performed by Matthew Maksoud, an 
MSc candidate in my lab. 
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and GAD65/67 in RAW 264.7 cells decreased significantly by a factor of 3.14 or 2.75 
respectively (Figures 3.13). Immunocytochemistry and confocal microscopy revealed LMϕs 
were immunopositive for both α2-GABAAR (Figure 3.14A) and GAD65/67 (Figure 3.14B) 
in LMϕs. Similar to effects observed in RAW264.7 cells, treatment with IFNγ significantly 
decreased the immunofluorescence intensity of GAD65/67 and α2-GABAAR in LMϕs by 
2.8 and 1.8 fold, respectively (Figure 3.14).  
A previous study demonstrated that neuronal NOS (nNOS) induces S-nitrosylation 
of gephyrin, a GABAAR scaffolding protein, decreasing synaptic GABAARs (Dejanovic & 
Schwarz, 2014). Thus, I examined whether LPS down-regulated GABAAR expression in 
RAW 264.7 macrophages through iNOS/NO signalling. My immunocytochemical analyses 
revealed positive immunofluorescence for both α2-GABAAR and gephyrin with low levels 
of co-localization in the plasma membrane and cytosol of RAW 264.7 cells (Figure 3.15, 
upper row). Interestingly, LPS treatment not only decreased the immunofluorescence of α2-
GABAAR and gephyrin in the cells, but also caused internalization of both proteins to 
intracellular structures, which were co-localized in structures visualized as fluorescent 
clusters (Figure 3.15, mid row). Notably, treating the cells with the iNOS inhibitor 1400W 
dihydrochloride largely eliminated the effect of LPS on the fluorescence intensity and 
cellular location of α2-GABAAR and gephyrin (Figure 3.15, lower row). These results 
suggested that activation of TLR4 by LPS regulates GABAAR expression and localization 
in macrophages likely through upregulation of iNOS activity.  Next, I performed double-
staining for α2-GABAAR and lysosomal-associated membrane protein 1 (LAMP-1) in 
control and LPS-treated RAW264.7 cells.  
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Figure 3.13. RAW 264.7 cells exhibit lower protein levels of α2-GABAAR and 
GAD65/67 in response to LPS and IFNγ. RAW 264.7 cells were treated with LPS 
(500ng/mL) or IFNγ (100ng/mL) for 16 hours.  Western blots showed that such treatments 
significantly decreased the expression of α2-GABAAR (A) and GAD65/67 (B). Plotted data 
represent mean ± SEM.  Significant difference (ANOVA/Dunnett’s test) p < 0.001 (***),     
n = 3. 
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Figure 3.14. M1 polarization reduces expression of α2-GABAAR and GAD65/67 in 
Primary LMϕs. Cultured LMs were treated with IFNγ (100ng/mL) for 16 hours to induce 
M1 polarization. The immunofluorescent intensity of α2-GABAAR (A) and GAD65/67 (B) 
significantly decreased in IFNγ-treated LMϕs. Plotted data represent mean ± SEM.  
Significant difference (unpaired T-test) p < 0.05 (*), p < 0.001 (***), n = 3. 
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Figure 3.15. LPS induced reduction and relocation of α2-GABAAR and gephyrin were 
reversed by inhibition of iNOS. Triple staining for α2-GABAAR (red), gephyrin (green) 
and DAPI (blue) was made in control RAW 264.7 cell (upper row), as well as cells treated 
with LPS (500ng/mL, mid row) or with LPS together with an iNOS inhibitor 1400W 
dihydrochloride (20µM, lower row) for 16 hours. Note that LPS treatment not only lowered 
the expression levels of α2-GABAAR and gephyrin, but also caused relocation of the two 
proteins to an intracellular structure. Treatment with 1400W dihydrochloride largely 
reversed the effect of LPS.  
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As shown in Figure 3.16, the immunofluorescence of α2-GABAAR and LAMP-1 
were partially co- localized. After LPS treatment, the intracellular α2-GABAAR clusters 
were associated with LAMP-1 clusters.  
I also explored whether the lowered level of α2-GABAAR and GAD65/67 proteins 
in LPS-treated macrophages was a result of activation of NF-κB pathway. To this end, 
RAW264.7 cells were treated with LPS, and LPS + BAY 11-7082, an inhibitor of IKK, a 
critical protein involved in NF-κB activation (Rauert-Wunderlich et al., 2013). Western blot 
assays revealed that the LPS induced an increase in the expression of both arginase-1 (Figure 
3.17A) and iNOS (Figure 3.17B) which was significantly decreased by the co-treatment 
with BAY 11-7082. BAY 11-7082 also significantly blocked the LPS-induced down-
regulation of GAD65/67 and α2-GABAAR in RAW264.7 cells (Figure 3.18). Furthermore, 
the increases in TNF-α (Figure 3.19A) and IL-10 (Figure 3.19B) secretion following LPS 
treatment were largely downregulated by BAY 11-7082. These results implicate that 
modulation of GAD65/67 and α2-GABAAR, as well as secreted cytokines TNF-α and IL-10 
occurs through the TLR4/NF-κB pathway.  
 
3.2.2 IL-4 + IL-13 increased expression of GABA signalling proteins 
I also investigated whether M2a polarization altered the levels of GABA signalling 
proteins. For this purpose, RAW 264.7 cells were treated with IL-4 and IL-13 for 16 hours. 
Western blot analysis revealed that these Th2 cytokines significantly increased protein level 
of both GAD65/67 by 1.36 fold and α2-GABAAR by 1.69 fold (Figure 3.20). Treating 
cultured LMϕs with IL-4 + IL-13 for 16 hours also greatly increased the immunofluorescent 
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Figure 3.16. LPS treatment relocated LAMP-1 together with α2-GABAAR in RAW 
264.7 cells. LAMP-1 and α2-GABAAR were immunostained in both control and LPS 
(500ng/mL) treated RAW264.7 cells. Sixteen hours after LPS treatment, 
immunofluorescence of LAMP-1 redistributed in RAW264.7 cells, becoming more uniform 
across the cell but with some large clusters. Interestingly, the large immunofluorescent 
clusters of α2-GABAAR were co-localized with the large immunofluorescent clusters of 
LAMP-1.   
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Figure 3.17. NF-κB inhibition reverses effects of LPS on arginase-1 and iNOS 
expression in RAW 264.7 cells. Western blots of control RAW 264.7 cells, and cells treated 
with LPS (500ng/mL) or with LPS + BAY 11-7082 (20µM) for 16 hours, were performed 
to assay arginase-1 (A) and iNOS (B) expression. Note that LPS upregulated the expression 
level of both arginase-1 and iNOS; and that the effects of LPS were reversed by the IKK 
inhibitor BAY 11-7082. Plotted data represent mean ± SEM. Significant difference 
(ANOVA/Tukey’s HSD) p < 0.01 (**), p < 0.001 (***), n = 3. 
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 Figure 3.18. NF-κB inhibition reverses LPS-mediated GAD65/67 and α2-GABAAR 
downregulation in RAW 264.7 cells. Western blots of lysates of control RAW 264.7 cells, 
and cells treated with LPS (500ng/mL) or with LPS + BAY 11-7082 (20µM) for 16 hours, 
were performed to assay GAD65/67 (A) and α2-GABAAR (B). LPS treatment down-
regulated the level of GAD65/67 and α2-GABAAR. This effect of LPS were reversed by the 
IKK inhibitor BAY 11-7082. Plotted data represent mean ± SEM.  Significant difference 
(ANOVA/Tukey’s HSD) p < 0.05 (*), n = 3. 
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Figure 3.19. NF-κB inhibition reverses LPS-induced TNF-α and IL-10 secretion in 
RAW 264.7 cells. (A) LPS (500ng/mL) causes an increase in TNF-α secretion. Pre-treatment 
with IKK inhibitor BAY 11-7092 reverses LPS-induced increase in cytokine secretion. (B) 
LPS (500ng/mL) greatly induced IL-10 secretion, however BAY 11-7092 completely 
reverses this effect. Plotted data represent mean ± SEM.  Significant difference 
(ANOVA/Tukey’s HSD) p < 0.01 (**), p < 0.0001 (****), n = 3.  
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Figure 3.20. Th2 cytokines increase expression of α2-GABAAR and GAD65/67 in RAW 
264.7 cells. Western blots of the lysates of control RAW 264.7 cells and cells treated with 
IL-4 (25ng/mL) + Il-13 (25ng/mL) for 16 hours were performed to assay the protein levels 
of α2-GABAAR (A) and GAD65/67 (B). Expression of α2-GABAAR and GAD65/67 were 
increased in RAW264.7 cells after IL-4 + IL-13 treatment. Plotted data represent mean ± 
SEM.  Significant difference (unpaired T-test) p < 0.01 (**), n = 3. 
 
 
 
 
 
 
 
 
 
 
A 
B 
68 
 
 
intensity of α2-GABAAR by 1.76 fold and GAD65/67 by 1.53 fold (Figures 3.21 and 3.22). 
Although addition of muscimol had no effect on the immunofluorescence intensity of α2-
GABAAR and GAD65/67, picrotoxin significantly decreased the immunofluorescence 
intensity of GAD65/67 in cultured LMϕs (Figure 3.22). Treating cultured LMϕs with IL-4 
+ IL-13 for 16 hours also greatly increased the immunofluorescence intensity of α2-
GABAAR by 1.76 fold and GAD65/67 by 1.53 fold (Figures 3.21 and 3.22). Although 
addition of muscimol had no effect on the immunofluorescence intensity of GAD65/67 and 
α2-GABAAR, picrotoxin significantly decreased the immunofluorescence intensity of 
GAD65/67 in cultured LMϕs (Figure 3.22). 
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Figure 3.21. IL-4 + IL-13 increases expression of α2-GABAAR in primary LMϕs. 
Primary LMϕs were treated with IL-4 (25ng/mL) + Il-13 (25ng/mL), or with IL-4 and IL-13 
+ muscimol (20µM) or picrotoxin (50µM). IL-4 + IL-13 treatment increased expression of 
α2-GABAAR (A). The addition of muscimol or picrotoxin to IL-4 + IL-13 had no effect. 
Plotted data represent mean ± SEM. Significant difference (ANOVA/Dunnett’s test) p < 0.01 
(**), n = 3. 
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Figure 3.22. IL-4 + IL-13 increases expression of GAD65/67 in primary LMϕs. Primary 
LMs were treated with IL-4 (25ng/mL) + Il-13 (25ng/mL), with IL-4 and IL-13 + muscimol 
(20µM) or picrotoxin (50µM). IL-4 + IL-13 treatment increased expression of GAD65/67. 
The addition of muscimol to IL-4 + IL-13 had no effect, however picrotoxin reduced 
GAD65/67 expression below control levels. Plotted data represent mean ± SEM. Significant 
difference (ANOVA/Dunnett’s test) p < 0.01 (**), p < 0.0001 (****), n = 3. 
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4.0 DISCUSSION 
Previous studies in my laboratory demonstrated that AMϕs express both GAD and 
GABAAR subunits indicating an autocrine GABA signalling mechanism exists in these cells. 
In addition, my honors thesis study found that blockade of GABAARs significantly increased 
secretion of the M1 cytokine TNF-α from AMϕs. The primary goal of this research project 
was to explore whether GABA signalling plays a role in phenotypic polarization of AMϕs. 
Specifically, I first determined if GABA signalling plays a role in LMϕ polarization, and 
then I studied whether the expression levels of GABA signalling proteins in LMϕs were 
modified with their phenotypic polarizations. The main results from this study showed that 
1) LMϕs displayed multifaceted polarizations under different microenvironments; 2) the 
expression levels of GABA signalling proteins in macrophages were up- or down-regulated 
depending on which agents were used to induce the phenotypic polarization; and 3) LMϕs 
are endowed with an autocrine GABA signalling mechanism that modulates phenotypic 
polarization of the cells.    
 
4.1 Multifaceted Macrophage Polarizations 
Data from converging studies indicate that macrophages are functionally polarized 
to M1 and M2 phenotypes in response to microorganisms and host mediators such as 
cytokines secreted from Th1/2 cells. Gene expression profiling of macrophages show that 
different Gram-negative and Gram-positive bacteria often induce the transcription of genes 
belonging to the M1 program. However, some bacterial pathogens provoke specific M2 
programs in macrophages (Benoit et al., 2008). Moreover, M2 macrophages cover a 
continuum of cell phenotypes, including M2a, M2b, and M2c subtypes with different 
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phenotypic and functional properties, depending on specific microenvironments. In order to 
understand the role of GABA signalling in M1/M2 polarization, one must first understand 
the complexities of macrophage polarization.  
  
4.1.1 M1 phenotype  
IFNγ is a typical Th1 cytokine. In agreement with previous findings demonstrating 
that IFNγ increases iNOS expression in murine macrophages (Stout et al., 2005, Staitieh et 
al., 2015), my results confirmed that IFNγ upregulates the M1 marker iNOS in both cell 
models (Figure 3.1). In contrast, IFNγ decreased the M2 marker arginase-1 in primary LMϕs 
(Figure 3.4).  
Increased secretion of TNF-α is often associated with M1 macrophages. My analyses 
demonstrated that IFNγ upregulates secretion of TNF-α in RAW264.7 cells (Figure 3.6), 
which agrees with a previous study performed in the same cell line. (Vila-del Sol et al., 
2008). IL-4 is a Th2 cytokine, and it is also secreted by macrophages (Gao et al., 2015). My 
assays showed that IL-4 secretion from control RAW264.7 cells was extremely low at 
baseline. Treatment of RAW 264.7 cells with IFNγ induced a slight decrease in IL-4 
following treatment, however this change was too small to be considered statistically 
significant. Baseline secretion of IL-4 from LMϕs was slightly higher than in RAW 264.7 
cells, and treating them with IFNγ significantly decreased the baseline secretion of IL-4 
(Figure 3.8).  
Taken together, my results showed that treating macrophages with IFNγ not only 
increased the M1 marker iNOS and the M1 cytokine TNF-α but also decreased the M2 
marker arginase-1 and the M2 cytokine IL-4, inducing a shift towards the M1 phenotype. 
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4.1.2 M2a phenotype 
Both IL-4 and IL-13 are secreted by Th2 cells and they use the IL-4Rα chain as a 
component of their receptors. Thus, these two cytokines are often used together to stimulate 
their receptors (Hershey, 2003). Several previous studies showed that IL-4 and/or IL-13 
increases arginase-1 expression via STAT6 signalling, and arginase-1 is cited as a marker 
for M2a phenotype in murine macrophages and cell lines (Müller et al., 2007; Sheldon et al., 
2013). My results showed the combination of IL-4 and IL-13 increased expression of 
arginase-1 in both RAW 264.7 cells and primary LMϕs (Figures 3.3 and 3.5).  
Past studies have demonstrated that IL-4 inhibits TNF-α secretion from human 
monocytes, and that IL-4 and IL-13 decrease TNF-α translation in RAW 264.7 cells (te 
Velde et al., 1990; Mijatovic et al., 1997).  In agreement with these previous studies, my 
results revealed that IL-4 + IL-13 significantly reduced TNF-α secretions from RAW 264.7 
cells, though only slightly reduced TNF-α secretions from primary LMϕs (Figure 3.7).   
It was interesting to observe that 16 hours after IL-4/IL-13 treatment the IL-4 
secretion largely increased in both RAW 264.7 cells and primary LMϕs (Figure 3.9). This 
finding is consistent with literature which reports that IL-4 is released from M2a 
macrophages (La Flamme et al., 2012; Murray et al., 2014, Gao et al., 2015). High levels of 
IL-10 secretion are associated with the M2 phenotype (Spellberg & Edwards, 2001; Lech & 
Anders, 2013; Yamaguchi et al., 2015). I therefore analyzed IL-10 as an example of an M2 
anti-inflammatory cytokine. Surprisingly, IL-4 + IL-13 treatment decreased IL-10 secretion 
from both RAW 264.7 cells and primary LMϕs (Figure 3.11). It is reported that IL-4 may 
act to suppress IL-10 secretion in human monocytes (Bonder et al., 1999), suggesting 
increased IL-10 secretion may not be associated with all M2 phenotypes. Nonetheless, 
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combined results from my experiments showed that IL-4 + IL-13 treatment induces M2a 
polarization of LMϕs. 
 
4.1.3 M2b phenotype 
M2b phenotype is a unique subtype of macrophages that often mediate inflammatory 
responses. Although arginase-1 expression has typically been used as a marker for M2 
polarization, some studies have suggested M2b and M2c phenotypes may be better 
characterized by high IL-10 and TGF-β secretion, respectively (Martinez et al., 2008; Saclier 
et al., 2013). For example, several studies have noted an increase in IL-10 release as a 
consequence of LPS stimulation, including in RAW 264.7 cells and human AMϕs (Chanteux 
et al., 2007, Van den Bosch et al., 2014). It is reported that M2b activation can be elicited by 
IL-1 receptor ligands, immune complexes, and LPS. Indeed, my assays showed that LPS 
treatment induced a great increase in IL-10 secretion (Figure 3.10) in RAW 264.7 cells and 
primary LMϕs, and an elevation of arginase-1 and expression (Figure 3.17) in RAW 264.7 
cells. These combined results may suggest that under these experimental conditions, LPS 
treatment induces M2b phenotype. However, the LPS-treated cells also displayed high levels 
of iNOS, which reflects the complicity of macrophage phenotypical development. Given that 
M1 macrophages are not associated with high levels of IL-10 secretion (Murray et al., 2014) 
and that a mixed M1/M2b phenotype has been identified in the population of microglia (Lisi 
et. al., 2014), a type of macrophage in the brain, it is plausible to propose that LMϕs share 
the same capability. 
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4.2 Macrophage polarization alters autocrine GABA signalling 
4.2.1 Decreased GABA signalling is associated with M1 and M2b phenotype 
My immunoblot assays showed that when cultured RAW 264.7 and LMϕs polarized 
to M1 phenotype by IFNγ treatment or to M2b by LPS treatment, the expression level of 
both GAD and α2-GABAAR decreased (Figure 3.13 and 3.14). This result is in line with 
the earlier studies in our lab, in which significant decrease in immunofluorescence of GAD 
and α2-GABAAR occurred in AMϕs of mice that were systemically treated with LPS. 
Considering that iNOS expression is largely increased in these cells and NO down-regulates 
GABAAR expression in neurons by S-nitrosylation of the GABAAR anchoring protein 
gephyrin (Dejanovic & Schwarz, 2014), I investigated the role of iNOS/NO in the regulation 
of GABAARs in RAW 264.7 cells. In RAW 264.7 cells, LPS treatment caused co-
localization and clustering of both gephyrin and α2-GABAAR inside of the cells, which was 
largely blocked by the iNOS inhibitor 1400W, suggesting iNOS/NO may be responsible for 
internalization of GABAARs (Figure 3.15). Furthermore, my studies demonstrated an 
association between α2-GABAAR and the lysosome marker LAMP-1 following LPS 
treatment (Figure 3.16), suggesting that the internalized GABAARs might be degraded 
within lysosomes. 
My results also showed that inhibition of the NF-κB signalling pathway in 
RAW264.7 cells by BAY 11-7082 not only significantly lowered the LPS-induced iNOS 
expression but also reduced the decrease in the expression of both GAD and α2-GABAAR 
(Figures 3.17 and 3.18). This finding was in line with a previous study, which reported that 
iNOS expression occurs through activation the NF-κB pathway (Aktan F, 2004). However, 
IFNγ treatment also yielded GAD and α2-GABAAR downregulation. The most well 
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understood downstream signalling of IFNγ is activation of STAT1, which has been 
suggested to be an important mediator of iNOS expression in epithelial cells (Stempelj et al., 
2007). More study could be done on STAT1 to fully elucidate the mechanisms involved in 
GAD and GABAAR downregulation, however our results highlight the importance of NF-
κB signalling.  
 
4.2.2 M2a polarization is associated with increased GABA signalling 
 My results showed that in response to IL-4 + IL-13 both RAW 264.7 cells and 
primary LMϕs displayed a significant upregulation of both GAD and α2-GABAAR (Figure 
3.20 and 3.21), although the signalling pathway through which Th2 cytokine upregulates 
the expression of GAD and GABAAR awaits further studies. Taken together my results 
demonstrated that M1/M2b polarization is linked to an overall decrease in GABA signalling, 
while M2a polarization is associated with an increase in GABA signalling (Figure 4.1). 
 
4.3 Autocrine GABA signalling regulates macrophage polarization 
4.3.1 Blockade of endogenous autocrine GABA signalling alters the phenotypic 
markers and cytokines  
 Results showed that at resting stage (M0), macrophages secreted GABA as evidenced 
by the occurrence of bicuclline-sensitive current in neurons when exposed to conditioned 
medium from RAW264.7 cells (Figure 3.12). To examine whether a GABAAR mediated 
autocrine signalling regulates macrophage phenotypical polarization, I treated RAW 264.7  
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Figure 4.1. Changes in GABAAR-mediated autocrine signalling and its role in 
macrophage polarization. Autocrine GABA signalling maintains the macrophage at a 
resting state (M0). Increased autocrine GABA signalling occurs in M2a phenotype while 
decreased GABA signalling is associated with M1 or M1/M2b phenotype. 
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cells and LMs with the GABAAR agonist muscimol and the GABAAR channel blocker 
picrotoxin. Results showed that muscimol did not affect the expression of iNOS, arginase-
1, GAD65/67 and α2-GABAAR, or the secreted cytokines. On the other hand, treating 
“naïve” AMϕs with picrotoxin significantly increased TNF-α secretion (Figure 1.7), while 
treating the IL-4/13 primed LMϕs with picrotoxin decreased IL-4 secretion along with 
arginase-1 and GAD expression (Figures 3.3, 3.5, 3.9, and 3.21). Notably, picrotoxin had 
no effect on TNF-α secretion from LPS-treated AMϕs (Figure 1.7), in which the expression 
of both GABAARs and GAD was greatly down-regulated (Figures 1.6 and 3.13). These 
results indicate that in M0 and M2a macrophages an active autocrine GABA signalling 
persistently regulates the function of the cells, whereas the autocrine GABA signalling is 
terminated when the cells shift to M1/M2b phenotypes.  
 
4.3.2 Potential mechanism by which autocrine GABA signalling regulates macrophage 
polarization 
GABAAR is a channel permeable for Cl
- and activation of this receptor leads to 
changes of membrane potential. My thesis study did not investigate the underlying 
mechanisms by which GABAAR regulates macrophage polarization. However, unpublished 
studies in my lab showed that activation of GABAAR can change intracellular Ca
2+ 
concentrations.  The enormous concentration difference between the extra- and intracellular 
compartments make Ca2+ entry to the cell a sensitive signal (Demaurex & Nunes, 2016). As 
a second messenger, intracellular Ca2+ plays a key role in the regulation of gene expression 
and cell differentiation (LoTurco et al., 1995, Johnson et al., 1997; van Haasteren et al., 
1999; Barbado et al., 2009). In excitable cells, membrane depolarization will result in the 
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opening of voltage-gated Ca2+ channels allowing for a large influx of Ca2+ due to the 
concentration gradient (Bers, 2008; Atlas, 2013). However, there has been no substantial 
evidence to support the expression of voltage-gated Ca2+ channels in immune cells. Instead, 
Ca2+ entry in non-excitable cells including macrophages is largely mediated by store-
operated Ca2+ entry (SOCE) through of the calcium-release activated channels (CRAC) on 
the plasma membrane allowing for Ca2+ entry (Putney et al., 2001).  
How can a GABAAR-mediated membrane potential change affect SOCE in 
macrophage? A study performed in peritoneal macrophages has demonstrated the resting 
potential of these macrophages is -75 mV, while the reversal potential for Cl- is -35.3 mV 
(Randriamampita & Trautmann, 1987). In essence, this means GABAAR stimulation at rest 
will result in an efflux of Cl- ions in peritoneal macrophages, although the resting and 
reversal potentials in LMs need to be determined. Due to the efflux of Cl- through the 
GABAAR channels and hence the more positive membrane potential, less Ca
2+ enters the 
cell. Results from my study showed that LPS downregulates GABAAR expression, which 
would result in a more negative membrane potential, and hence a larger Ca2+ influx to the 
cells.  
My results showed that M2a polarization results in a feedforward GABA signalling 
marked by increased GAD and α2-GABAAR, leading to upregulation of IL-4 secretion. M2a 
polarization might reduce Cl- influx channel NKCC expression but increase Cl- efflux 
channel KCC expression causing a lowered intracellular Cl- concentration. Consequently, 
upon GABAAR activation there will be Cl
- influx causing membrane hyperpolarization, 
more Ca2+ entry and activated M2 gene expression. (Figure 4.2). 
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Figure 4.2. Proposed mechanisms by which the GABAAR mediated autocrine signalling 
regulates phenotypic polarization and function of macrophages. In “resting 
macrophages (M0), the higher expression and activity levels of the Cl- intruding NKCC and 
the lower expression and activity levels of the Cl- extruding KCC results in a higher 
intracellular Cl- concentration. Therefore, autocrine GABA activates GABAARs mediating 
Cl- efflux, which consequently maintain the transmembrane membrane potential depolarized 
(less negative) and minimum Ca2+ entry through store-operated calcium (SOC) channels. 
M1 polarization results in a decreased expression of GABAARs and GAD, causing 
membrane hyperpolarization and more Ca2+ entry through SOC channels, consequently M1 
gene expression. In contrast, M2 polarization results in an increased expression of 
GABAARs and GAD. However, M2 polarization might reduce NKCC expression but 
increase KCC expression and thus shift the reversal potential of Cl-, consequently resulting 
in Cl- influx through GABAARs, hence membrane hyperpolarization, more Ca
2+ entry and 
activated M2 gene expression.    
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As previously mentioned, changes in Ca2+ signalling may also play a role in 
macrophage polarization by modification of gene transcription. Although exact mechanisms 
are still under investigation, several factors have been suggested to play important roles in 
Ca2+ mediated alterations in gene expression, including, nuclear factor of activated T-cells, 
and NF-Κb. Changes in Ca2+ signalling related to changes in Cl- flow before and after 
neuronal maturation may be an indicator that differential gene expression may be related to 
phenotype change, and in LMϕs GABA/Ca2+ signalling may play an important role in 
phenotypic shifts seen in this study (Nachtomy et al., 2007).  
 
4.4 Future studies 
Several measures could be taken to strengthen already existing findings. Treatments 
and time points used in these experiments were based on treatments established in the 
literature. However, in the future dose-response curves should be established for each drug. 
Multiple time points should also be examined, which may be particularly important for 
examining how LMϕs/RAW 264.7 cells change phenotype and/or cytokine secretion over 
time. Along the same vein many studies could be repeated using bicuculline in the place of 
picrotoxin, since bicuculline is selective antagonist for GABAARs rather than a channel 
blocker. Several additional experimental methods could also be applied to strengthen the 
current studies, including proteomics to further examine cytokine production, and real-time 
PCR to examine RNA expression of GAD and α2-GABAARs at various time points 
following treatments with IFNγ, LPS, and IL-4 + IL-13. Furthermore, fluorescence-activated 
cell sorting should be done following LMϕ extraction from lung tissue based on differential 
expression of CD11, allowing for separation and independent study of IMϕ and AMϕ 
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populations. Finally, although it has been demonstrated that RAW 264.7 cell media 
contained secreted GABA, the same has not yet been confirmed in LM media. Therefore, 
the same patch clamping study we performed using cultured hippocampal neurons should be 
carried out once again. Patch clamping studies should also be performed using primary 
LMϕs to determine the resting membrane potential, and direction of Cl- flow following 
GABAergic stimulation. 
 There are also areas which could be expanded upon in future study. Given that this 
study did not fully establish a mechanism for GABAAR downregulation, it is possible other 
unexplored mechanisms may be responsible. In neurons it has been suggested that GABAAR 
reduction may be attributed to degradation of receptor proteins followed by a decrease in de 
novo synthesis (Barnes EM Jr, 1996). One method that could be used to further investigate 
the fate of decreased GABAAR expression is by a biotin degradation assay. Biotinylation 
techniques may also be useful for investigating receptor endocytosis, which would confirm 
GABAARs are being internalized into lysosomes as suspected. In this instance GABAARs 
may be pretreated prior to biotinylation with a lysosomal inhibitor such as leupeptin to 
prevent proteolysis. A Western blot may then be run wherein the higher expression of biotin 
represents GABAAR internalization. (Mammen et al., 1997; Arancibia-Cárcamo et al., 
2006). Biotin may also be useful for further examining whether upregulated iNOS is related 
to gephyrin nitrosylation in LMϕs/RAW 264.7 cells. One particular study known as the 
biotin-switch technique can effectively replace S-nitrosylated cysteine residues with biotin 
for relatively easy detection (Forrester et al., 2009). Receptor upregulation in M2a 
polarization should also be further examined. It is known that IL-4/IL-13 function primarily 
through the transcription factor STAT6, therefore one study that could be done involves 
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treatment with IL-4/IL-13 while inhibiting STAT6. Changes in GAD and α2-GABAAR 
could then be observed via Western blot, confocal microscopy, and/or PCR. 
 My results suggested a potential mechanism for changes in intracellular Cl- 
concentration related to macrophage phenotypes. These changes are proposed to be due to 
differential expression of NKCC and KCC channels during polarization. In order to 
investigate the proposed mechanism, Western blots may be performed for KCC and NKCC 
in IFNγ and IL-4 + IL-13 treated cells. 
 The ultimate goal for studying GABA signalling in LMϕs should involve in vivo 
studies. Although in vitro studies allow for examination of isolated populations of single cell 
types, this is not necessarily realistic. Other cells including Type II epithelial cells and T 
cells reside in the environment and are constantly secreting factors which affect macrophage 
polarization. Furthermore, studies have shown T cells secrete GABA and studies in our 
laboratory have found that Type II epithelial cells also possess GABA signalling systems 
(Bhat et al., 2010; Prud’Homme et al., 2013, Xiang et al., 2013). Therefore, GABA 
signalling interactions between these cell types may also affect inflammatory responses 
within the pulmonary immune system. 
 
4.5 Limitations  
 Although the findings outlined in the present study suggest an important role for 
GABA signalling as a regulator of LMϕ inflammatory response, there are several limitations 
to be considered. Due to the low number of primary LMϕs that could be obtained via lung 
digest, immunofluorescence techniques were utilized to measure changes in markers 
involved in cellular polarization, as well as GABA signalling proteins. Immunofluorescent 
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techniques have inherent limitations, including a potential for non-specific protein binding 
with fluorescent antibodies, and photo-bleaching. In addition, the results of fluorescence 
intensity are qualitative in nature. Regarding the selected experimental treatment groups, 
controls were not run for muscimol or picrotoxin, therefore it is unknown how these drugs 
would affect the cell on their own. Furthermore, only one type of agonist/antagonist were 
used at fixed concentrations, therefore it is difficult to ensure all results are induced by the 
intended purpose of the drug or an unanticipated side effect. Finally, all experiments in this 
study focussed on either the RAW 264.7 cell line or LMϕs in isolation. While these studies 
are good for investigating the role of GABA signalling within this specific cell type, it is 
likely the case that the cells would function differently in vivo when surrounded by 
neighboring immune cells. 
 
4.6 Conclusion and significance  
This study is the first to link GABA signalling in AMϕs to phenotypic polarization. 
First, it was found that blockade of GABAAR with picrotoxin shifts the cell towards M1 
phenotype, while muscimol had no effect. This finding led to the discovery that RAW 264.7 
cells possess an autocrine GABA signalling system, as they express GAD, produce GABA, 
and express α2-GABAARs. My study established a link between LMϕ polarization and 
GABA signalling. Increased GABA signalling is associated with M2a polarization, while a 
decrease in GABA signalling is related to M1 and M2b phenotypes. These findings provide 
insight for a novel role of endogenous GABA signalling as a regulator of LMϕ polarization 
and inflammatory response. Specifically, tonic GABA signalling provides feedback 
inhibition of pro-inflammatory cytokine release. IFNγ and LPS decrease GABA signalling, 
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leading to the release of pro-inflammatory cytokines. Conversely GABA signalling feeds 
forward to M2a polarization, inducing secretion of IL-4. Primarily, I propose changes in 
GABA signalling associated with polarization regulates Ca2+ signalling and consequently 
cytokine release and potentially transcriptional changes. This may have therapeutic 
implications, providing further insight that GABA may be an effective immunomodulatory 
signalling molecule (Bhat et al., 2010; Prud’homme et al., 2013). 
 Differential GABAAR expression may also be a useful indicator for phenotypic 
polarization. Currently classification of different macrophage phenotypes is confusing, with 
different markers sometimes being used to classify the same phenotypes. Currently an effort 
within the immunology is to define a unified set of markers to distinguish between different 
macrophage phenotypes (Murray et al., 2014). The standardization of marker usage would 
benefit experienced researchers as well as those entering the field, by establishing definite 
associations between markers and phenotypes. Results from my studies demonstrate distinct 
GABAAR expression patterns in different phenotypical macrophages, therefore expression 
levels of this receptor may aid in the classification of macrophage subtypes.  
LMϕs display a plastic nature and play key roles in pulmonary functions and 
diseases. This study demonstrates that autocrine GABA signalling regulates the plasticity of 
LMϕs. The challenge remains to apply the knowledge generated from mechanistic studies 
of LMϕs towards pulmonary physiology and directed therapies for the treatment of 
pulmonary disease. I propose that pharmacological manipulation of GABA signalling within 
the lung may be a potential treatment for lung inflammation, in particular the M2/Th2 
inflammation associated with pulmonary allergy and asthma. Specifically, this study 
demonstrates an increase in GABA signalling associated with M2a polarization, it may be 
86 
 
 
possible that antagonism of this GABA signalling may restrain M2/Th2 inflammation. 
Nevertheless, LMϕs are not the only immune cells which exhibit GABA signalling. Studies, 
including some in our lab, have demonstrated that T lymphocytes and type II alveolar 
epithelial cells possess autocrine GABA signalling mechanisms, which could interact with 
the GABA signalling system in LMϕs. Therefore, more in vivo studies is imperative for 
establishing the notion of GABA signalling as an immune regulator. 
 In conclusion, this study has demonstrated that LMϕs possess an autocrine GABA 
signalling mechanism which has important implications in regulation of inflammatory 
responses. Specifically, the role of autocrine GABA signalling in LMϕs is to provide 
feedback inhibition to the M1/M2b phenotype, and feedforward activation to the M2a 
phenotype. 
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